ROGERS JOHN (US)
US20140364337A1 | 2014-12-11 |
SUZANNE SMITH ET AL: "Abstract 1841: Enrichment of IGF1R-AKT-mTOR pathway proteins using immunoprecipitation and proteomic analysis by mass spectrometry | Cancer Research", PROCEEDINGS: AMERICAN ASSOCIATION FOR CANCER RESEARCH 106TH ANNUAL MEETING 2015; APRIL 18-22, 2015; PHILADELPHIA, PA, USA. CANCER RESEARCH, vol. 75, no. 15 Suppl, 1 August 2015 (2015-08-01), XP055379897
TOVE BOSTROEM ET AL: "Investigating the Applicability of Antibodies Generated within the Human Protein Atlas as Capture Agents in Immunoenrichment Coupled to Mass Spectrometry", JOURNAL OF PROTEOME RESEARCH., vol. 13, no. 10, 3 October 2014 (2014-10-03), US, pages 4424 - 4435, XP055398670, ISSN: 1535-3893, DOI: 10.1021/pr500691a
BHAVIN PATEL ET AL: "Quantitative analysis of IGF1R/AKT/mTOR pathway using multiplex immunoprecipitation and targeted mass spectrometry", THERMO SCIENTIFIC, 15 July 2016 (2016-07-15), pages 1 - 3, XP055470279, Retrieved from the Internet
JOHN C. ROGERS: "Quantitative Analysis of Two cancer Signalling Pathways Using Multiplex-Immunoprecipitation and Targeted Mass Spectrometry", 1 January 2015 (2015-01-01), ThermoFischer, XP055470285, ISBN: 978-1-4939-2210-9, Retrieved from the Internet
MENDOZA MC; ER EE; BLENIS J., TRENDS BIOCHEM SCI., vol. 36, no. 6, June 2011 (2011-06-01), pages 320 - 8
GINGRAS ET AL., NAT. REV. MOL. CELL. BIOL., vol. 8, no. 8, August 2007 (2007-08-01), pages 645 - 54
CARR, S. A. ET AL., MOL. CELL. PROTEOMICS, vol. 13, no. 3, March 2014 (2014-03-01), pages 907 - 17
CHAMBERS ET AL., EXPERT REV. PROTEOMICS, 2014, pages 1 - 12
We claim: 1. A method for detecting RAS-RAF-MAPK pathway proteins, comprising a. treating a biological sample with at least one antibody capable of immunoprecipitating RAS-RAF-MAPK pathway protein(s) from a biological sample; b. digesting the immunoprecipitated target protein(s); c. assaying the digested protein(s) via mass spectrometry to determine the presence or absence of a peptide for RAS-RAF-MAPK pathway protein(s), wherein the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400, and is less than or equal to 40 amino acids in length; and d. detecting one or more RAS-RAF-MAPK pathway protein(s) in the sample. 2. The method of claim 1, further comprising determining the quantity of RAS-RAF- MAPK pathway protein. 3. A method for detecting RAS-RAF-MAPK pathway proteins, comprising a. isolating proteins from a biological sample; b. digesting the isolated proteins; c. assaying the digested protein(s) via mass spectrometry to determine the presence or absence of a peptide for RAS-RAF-MAPK pathway protein(s), wherein the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400, wherein the peptide is less than or equal to 40 amino acids in length; and d. detecting one or more RAS-RAF-MAPK pathway protein(s) in the sample. 4. The method of claim 3, further comprising determining the quantity of RAS-RAF- MAPK pathway protein. 5. The method of any one of the preceding claims, wherein the RAS-RAF-MAPK pathway protein is phosphorylated. 6. The method of any one of the preceding claims, wherein the RAS-RAF-MAPK pathway peptide comprises at least one peptide of Table 5. 7. A method for determining the ratio of phosphorylated to non-phosphorylated RAS- RAF-MAPK pathway proteins, comprising a. treating a biological sample with one or more antibodies capable of immunoprecipitating a phosphorylated RAS-RAF-MAPK target protein, and separately treating the same biological sample with one or more antibodies capable of immunoprecipitating a non-phosphorylated RAS-RAF-MAPK target protein; b. digesting the immunoprecipitated RAS-RAF-MAPK pathway proteins; c. adding a first and a second detectably labelled internal standard peptide of known amount to the digested proteins, wherein the first internal standard peptide has the same amino acid sequence as a phosphorylated RAS-RAF- MAPK pathway peptide used to identify the phosphorylated protein, and the second internal standard peptide has the same amino acid sequence as the non- phosphorylated RAS-RAF-MAPK pathway peptide used to identify the non- phosphorylated protein; d. assaying the digested protein and internal standards via mass spectrometry to determine the presence and amount of phosphorylated and non-phosphorylated RAS-RAF-MAPK pathway peptides, wherein the RAS-RAF-MAPK pathway peptide is chosen from of SEQ ID NO: 1 - SEQ ID NO: 1400; and e. determining the quantity of RAS-RAF-MAPK phosphorylated and non- phosphorylated pathway proteins in the sample, and determining the ratio of phosphorylated to non-phosphorylated target proteins. 8. The method of any one of the preceding claims, wherein the biological sample is human. 9. The method of any one of the preceding claims, wherein the peptide is wherein the RAS-RAF-MAPK pathway peptide comprises at least one peptide of Table 5. 10. The method of any one of the preceding claims, wherein the antibody to detect non- phosphorylated RAS-RAF-MAPK pathway protein comprises an antibody of Table 6. 11. The method of any one of the preceding claims, wherein the peptide is modified with a detectable label. 12. The method of claim 11, wherein the detectable label comprises an isotope selected from 13C, 15N, 2H and 180. 13. The method of claim 11, wherein the modified peptide comprises a peptide of SEQ ID NO: 701-1400. 14. The method of any one of claims 1, 2, and 5-13, wherein the antibody is chosen from the antibodies recited in Table 1. 15. The method of claim 14, wherein the antibody is capable of immunoprecipitating more than one RAS-RAF-MAPK pathway protein. 16. The method of claim 15, wherein the more than one RAS-RAF-MAPK pathway proteins are chosen from: a. KRAS, HRAS, and NRAS; b. EGFR, SOS1, ARAF, BRAF, RAF1, KRAS, HRAS, and NRAS, RPS6KA1, PIK3R1, PIK3R2 and PIK3CA; c. ERBB2, SOS1, ARAF, BRAF, RAF1, KRAS, HRAS, and NRAS, RPS6KA1, PIK3R1, PIK3R2 and PIK3CA; d. SPRY1, SPRY2, DUSP4, RASA1, NF1, SPRED1, SPRED2, KRAS, HRAS, and NRAS; e. MAPK1/3 and TP53 are evaluated together (such as, for example MAPK1/3 phosphorylated form pThr202/pTyr204 and TP53 phosphorylated form pSerl5); or f. PIK3R1, PIK3R2, PIK3CA, ARAF, BRAF, RAF1, KRAS, HRAS, NRAS, RPS6KA1, RPS6KB1, AKT1, AKT2, AKT3, MTOR, phosphor- TP53 (pSerl5) and phosphor-MAPKl/3 (pThr202/pTyr204). 17. The method of claim 16, wherein the antibodies used are from combinations B, C, D, E, F, or G in Table 7. 18. The method of any one of claims 1, 2, and 5-17, wherein the method evaluates both non-phosphorylated and phosphorylated versions of at least one RAS-RAF-MAPK pathway protein comprising: g. employing a first antibody capable of immunoprecipitating phosphorylated version of the RAS-RAF-MAPK pathway protein, and a second antibody capable of immunoprecipitating a phosphorylated and non-phosphorylated RAS-RAF-MAPK pathway protein precipitated by the first antibody or h. dividing the sample into two aliquots and immunoprecipitating either total or non-phosophorylated RAS-RAF-MAPK pathway protein from a first aliquot and immunoprecipitating a phosphorylated version of the RAS-RAF-MAPK pathway protein from second aliquot. 19. The method of claim 18, wherein total TP53 and phosphorylated TP53 are evaluated together. 20. The method of claim 19, wherein the antibodies used are from combination A in Table 7. 21. The method of any one of claims 1, 2, and 5-20, wherein step a) comprises treating the sample with a labelled antibody capable of binding to the pathway protein to provide a labelled antibody-protein conjugate; and binding the labelled antibody-protein conjugate with a capture agent capable of binding to the labelled antibody to isolate the target protein from the sample. 22. The method of claim 21, wherein the label is biotin and the capture agent is streptavidin. 23. The method of any one of the preceding claims, wherein the quantity of a RAS-RAF- MAPK pathway protein is determined by adding an internal standard peptide of known amount to the digested protein prior to mass spectrometry, wherein the internal standard peptide has the same amino acid sequence as the RAS-RAF-MAPK pathway peptide, and is detectably labeled, and determining the quantity of a RAS-RAF-MAPK pathway peptide by comparison to the internal standard. 24. The method of any one of the preceding claims, wherein the quantity of a RAS-RAF- MAPK pathway protein is determined by a method comprising comparing an amount of a RAS-RAF-MAPK pathway peptide in the sample to the amount of the same RAS- RAF-MAPK pathway peptide in a control sample. 25. The method of any one of the preceding claims, wherein the quantity of a RAS-RAF- MAPK pathway protein is determined by a method comprising comparing an amount of the RAS-RAF-MAPK pathway peptide to an internal standard peptide of known amount, wherein both the peptide in the biological sample and the internal standard peptide are chosen from SEQ ID NO: 1- SEQ ID NO: 701, wherein the standard peptide is detectably labeled. 26. The method of any of claims 23 and 25, wherein the internal standard peptide is chosen from SEQ ID NO: 1 - SEQ ID NO: 700. 27. The method of any of claims 23 and 25, wherein the internal standard peptide is chosen from SEQ ID NO: 701 - SEQ ID NO: 1400. 28. The method of any of the preceding claims, wherein the mass spectrometry is selected from tandem mass spectrometry and discovery mass spectrometry. 29. The method of claim 28, wherein the targeted mass spectrometry is selected from multiple reaction monitoring (MRM), selected reaction monitoring (SRM), and parallel reaction monitoring (PRM), or combinations thereof. 30. The method of any one of the preceding claims, wherein the biological sample is selected from isolated cells, plasma, serum, whole blood, CSF, urine, sputum, tissue, and tumorous tissue. 31. The method of any one of the preceding claims, further comprising quantifying the relative amount of RAS-RAF-MAPK pathway protein. 32. The method of any one of the preceding claims, further comprising quantifying the absolute amount of RAS-RAF-MAPK pathway protein. 33. The method of any one of the preceding claims, wherein the digesting comprises a protease or chemical digest. 34. The method of any one of the preceding claims, wherein the digestion is single or sequential. 35. The method of any of claims 33 and 34, wherein the protease digestion is with trypsin, chymotr psin, AspN, GluC, LysC, LysN, ArgC, proteinase K, pepsin, clostripain, elastase, GluC biocarb, LysC/P, LysN promise, protein endopeptidase, staph protease or thermolysin. 36. The method of any of claims 33 and 34, wherein the chemical cleavage is with CNBr, iodosobenzoate or formic acid. 37. The method of any of claims 33 and 34, wherein the protease digest is a trypsin digest. 38. The method of any of the preceding claims, further comprising desalting after digestion and prior to mass spectrometry. 39. The method of any one of the preceding claims, wherein the RAS-RAF-MAPK pathway protein is chosen from ALK (UniProtKB - Q9UM73), ARAF (UniProtKB - P10398), BRAF (UniProtKB - P15056), CALM1 (UniProtKB - P62158), CAMK2A (UniProtKB - Q9UQM7), CCND1 (UniProtKB - P24385), CDH1 (UniProtKB - P12830), CDH2 (UniProtKB - P19022), CDK2 (UniProtKB - P24941), CDKN1A (UniProtKB - P38936), CDKN1B (UniProtKB - P46527), CDKN2A (UniProtKB - Q8N726), CTNNA1 (UniProtKB - P35221), CTNNB1 (UniProtKB - P35222), DDR2 (UniProtKB - Q 16832), DUSP22 (UniProtKB - Q9NRW4), DUSP4 (UniProtKB - Q13115), DUSP6 (UniProtKB - Q16828), EGFR (UniProtKB - P00533), EIF2A (UniProtKB - Q9BY44), EIF4E (UniProtKB - P06730), EIF4EBP1 (UniProtKB - Q13541), ERBB2 (UniProtKB - P04626), ERBB3 (UniProtKB - P21860), ERBB4 (UniProtKB - Q15303), ESR1 (UniProtKB - P03372), FBX07 (UniProtKB - Q9Y3I1), FGFR1 (UniProtKB - PI 1362), FGFR3 (UniProtKB - P22607), FOS (UniProtKB - P01100), FOXOl (UniProtKB - Q12778), FOX03 (UniProtKB - 043524), HRAS (UniProtKB - P01112), IQGAP1 (UniProtKB - P46940), JAK1 (UniProtKB - P23458), JAK2 (UniProtKB - 060674), KRAS (UniProtKB - P01116), MAP2K1 (UniProtKB - Q02750), MAP2K2 (UniProtKB - P36507), MAPK1 (UniProtKB - P28482), MAPK11 (UniProtKB - Q15759), MAPK3 (UniProtKB - P27361), MAPK8 (UniProtKB - P45983), MAPK9 (UniProtKB - P45984), MET (UniProtKB - P08581), NF1 (UniProtKB - P21359), NOTCH1 (UniProtKB - P46531), NRAS (UniProtKB - P01111), PAK1 (UniProtKB - Q13153), PARP1 (UniProtKB - P09874), PGR (UniProtKB - P06401), PIK3CA (UniProtKB - P42336), PIK3R1 (UniProtKB - P27986), PIK3R2 (UniProtKB - 000459), PSMG1 (UniProtKB - 095456), RAF1 (UniProtKB - P04049), RASA1 (UniProtKB - P20936), RASGRF1 (UniProtKB - Q13972), RASGRF2 (UniProtKB - 014827), RICTOR (UniProtKB - Q6R327), RPS6KA1 (UniProtKB - Q15418), RPS6KA2 (UniProtKB - Q15349), RPS6KA3 (UniProtKB - P51812), RPS6KB2 (UniProtKB - Q9UBS0), RPTOR (UniProtKB - Q8N122), SMAD3 (UniProtKB - P84022), SMAD4 (UniProtKB - Q13485), SOS 1 (UniProtKB - Q07889), SPRED1 (UniProtKB - Q7Z699), SPRED2 (UniProtKB - Q7Z698), SPRY1 (UniProtKB - 043609), SPRY2 (UniProtKB - 043597), SPRY3 (UniProtKB - 043610), SPRY4 (UniProtKB - Q9C004), STAT1 (UniProtKB - P42224), STAT3 (UniProtKB - P40763), STK11 (UniProtKB - Q15831), TP53 (UniProtKB - P04637), ATF2 (UniProtKB - P15336), MAPK12 (UniProtKB - P53778), MAPK13 (UniProtKB - 015264), MAPK14 (UniProtKB - Q16539), MAP2K3 (UniProtKB - P46734), MAP2K6 (UniProtKB - P52564), RPS6KA5 (UniProtKB - 075582), and MAPKAPK2 (UniProtKB - P49137). 40. The method of any one of the preceding claims, wherein the RAS-RAF-MAPK pathway protein is selected from the proteins recited in claim 39, or proteins that interact with the proteins recited in claim 39. 41. The method of any one of the preceding claims, wherein the RAS-RAF-MAPK protein is phosphorylated. 42. The method of any one of the preceding claims, wherein the concentration of RAS- RAF-MAPK peptide detected ranges from 0.04 fmol to 2000 fmol. 43. The method of any one of the preceding claims, wherein the lower limit of detection is no more than 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.20, 0.21, 0.22, 0.23, 0.24, or 1.23 fmol. 44. The method of any one of the preceding claims, wherein the lower limit of detection is from 0.04 - 1.23 fmol. 45. The method of any one of the preceding claims, wherein the lower limit of quantification is no more than 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.20, 0.21, 0.22, 0.23, 0.24, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50, 0.55, 0.60, 0.65, 0.70, or 11.11 fmol. 46. The method of any one of the preceding claims, wherein the lower limit of quantification is from 0.04 - 11.11 fmol. 47. A kit comprising one or more antibodies capable of immunoprecipitating a RAS-RAF- MAPK pathway protein. 48. A kit comprising one or more antibodies capable of immunoprecipitating a RAS-RAF- MAPK pathway protein, and reagents useful for performing mass spectrometry to detect the one or more RAS-RAF -MAPK pathway protein. 49. A kit comprising one or more antibodies capable of immunoprecipitating a RAS-RAF- MAPK pathway protein, and reagents useful for performing mass spectrometry to detect and quantify a RAS-RAF-MAPK pathway protein. 50. A kit comprising one or more RAS-RAF-MAPK pathway peptides comprising the peptides of SEQ ID NO: 1 - SEQ ID NO: 1400, wherein the peptide is less than or equal to 40 amino acids. 51. A kit comprising one or more RAS-RAF-MAPK pathway peptides consisting of SEQ ID NO: 1 - SEQ ID NO: 1400. 52. The kit according to any one of claims 47-51, wherein the peptide is selected from the peptides recited in Table 5. 53. The kit according to any one of claims 47-52, wherein the antibody is selected from the antibodies recited in Table 1. 54. The kit according to any one of claims 47-52, wherein the antibody is selected from the antibodies recited in Table 6. 55. The kit according to any one of claims 47-54, further comprising at least one peptide selected from peptides of SEQ ID NO: 1 - SEQ ID NO: 700, wherein the peptide is less than or equal to 40 amino acids. 56. The kit of according to any one of claims 47-54, comprising at least one peptide selected from peptides of SEQ ID NO: 701 - SEQ ID NO: 1400, wherein the peptide is less than or equal to 40 amino acids. 57. The kit of claims according to any one of claims 47-54, comprising at least one peptide selected from peptides of SEQ ID NO: 1 - SEQ ID NO: 700, wherein the peptide is less than or equal to 40 amino acids, and wherein the peptide is detectably labeled or capable of being modified to be detectably labeled. 58. The kit of any one of claims 47-54, further comprises a protease or chemical agent capable of digesting an immunoprecipitated protein sample. 59. The kit of claim 58, wherein the protease agent is trypsin, chymotrypsin, AspN, GluC, LysC, LysN, ArgC, proteinase K, pepsin, clostripain, elastase, GluC biocarb, LysC/P, LysN promise, protein endopeptidase, Staph protease or thermolysin. 60. The kit of claim 58, wherein the chemical agent is CNBr, iodosobenzoate or formic acid. 61. The kit of any of claims 47-60, wherein the RAS-RAF-MAPK pathway protein is chosen from ALK (UniProtKB - Q9UM73), ARAF (UniProtKB - PI 0398), BRAF (UniProtKB - PI 5056), CALM1 (UniProtKB - P62158), CAMK2A (UniProtKB - Q9UQM7), CCND1 (UniProtKB - P24385), CDH1 (UniProtKB - P12830), CDH2 (UniProtKB - PI 9022), CDK2 (UniProtKB - P24941), CDKN1A (UniProtKB - P38936), CDKN1B (UniProtKB - P46527), CDKN2A (UniProtKB - Q8N726), CTNNA1 (UniProtKB - P35221), CTNNB1 (UniProtKB - P35222), DDR2 (UniProtKB - Q 16832), DUSP22 (UniProtKB - Q9NRW4), DUSP4 (UniProtKB - Q13115), DUSP6 (UniProtKB - Q16828), EGFR (UniProtKB - P00533), EIF2A (UniProtKB - Q9BY44), EIF4E (UniProtKB - P06730), EIF4EBP1 (UniProtKB - Q13541), ERBB2 (UniProtKB - P04626), ERBB3 (UniProtKB - P21860), ERBB4 (UniProtKB - Q15303), ESR1 (UniProtKB - P03372), FBX07 (UniProtKB - Q9Y3I1), FGFR1 (UniProtKB - PI 1362), FGFR3 (UniProtKB - P22607), FOS (UniProtKB - P01100), FOXOl (UniProtKB - Q12778), FOX03 (UniProtKB - 043524), HRAS (UniProtKB - P01112), IQGAP1 (UniProtKB - P46940), JAK1 (UniProtKB - P23458), JAK2 (UniProtKB - 060674), KRAS (UniProtKB - P01116), MAP2K1 (UniProtKB - Q02750), MAP2K2 (UniProtKB - P36507), MAPK1 (UniProtKB - P28482), MAPK11 (UniProtKB - Q15759), MAPK3 (UniProtKB - P27361), MAPK8 (UniProtKB - P45983), MAPK9 (UniProtKB - P45984), MET (UniProtKB - P08581), NF1 (UniProtKB - P21359), NOTCH1 (UniProtKB - P46531), NRAS (UniProtKB - P01111), PAK1 (UniProtKB - Q13153), PARP1 (UniProtKB - P09874), PGR (UniProtKB - P06401), PIK3CA (UniProtKB - P42336), PIK3R1 (UniProtKB - P27986), PIK3R2 (UniProtKB - 000459), PSMG1 (UniProtKB - 095456), RAF1 (UniProtKB - P04049), RASA1 (UniProtKB - P20936), RASGRF1 (UniProtKB - Q13972), RASGRF2 (UniProtKB - 014827), RICTOR (UniProtKB - Q6R327), RPS6KA1 (UniProtKB - Q15418), RPS6KA2 (UniProtKB - Q15349), RPS6KA3 (UniProtKB - P51812), RPS6KB2 (UniProtKB - Q9UBS0), RPTOR (UniProtKB - Q8N122), SMAD3 (UniProtKB - P84022), SMAD4 (UniProtKB - Q13485), SOS 1 (UniProtKB - Q07889), SPRED1 (UniProtKB - Q7Z699), SPRED2 (UniProtKB - Q7Z698), SPRY1 (UniProtKB - 043609), SPRY2 (UniProtKB - 043597), SPRY3 (UniProtKB - 043610), SPRY4 (UniProtKB - Q9C004), STAT1 (UniProtKB - P42224), STAT3 (UniProtKB - P40763), STK11 (UniProtKB - Q15831), TP53 (UniProtKB - P04637), ATF2 (UniProtKB - P15336), MAPK12 (UniProtKB - P53778), MAPK13 (UniProtKB - 015264), MAPK14 (UniProtKB - Q16539), MAP2K3 (UniProtKB - P46734), MAP2K6 (UniProtKB - P52564), RPS6KA5 (UniProtKB - 075582), and MAPKAPK2 (UniProtKB - P49137). 62. The kit of any of claims 47-61, wherein the RAS-RAF-MAPK protein is phosphorylated. 63. A method for immunoprecipitating a RAS-RAF-MAPK pathway protein comprising contacting a biological sample with any one of the antibodies recited in Table 1. |
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority of US Provisional Application
No. 62/465,102, filed February 28, 2017, which is incorporated by reference in its entirety for any purpose.
SEQUENCE LISTING
[0002] The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on February 22, 2018, is named 2018-02-22_01129-0062- 00PCT_Seq_List_ST25 and is 485 kilobytes in size.
FIELD OF THE INVENTION
[0003] This disclosure relates to the field of detection and quantification of RAS-RAF-
MAPK pathway proteins, including adjacent pathway proteins, by immunoprecipitation and mass spectrometry.
BACKGROUND
[0004] The RAS-RAF-MAPK and AKT-mTOR signaling pathways are key regulators of several aspects of normal cell growth and malignant transformation such as cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. These two pathways extensively engage in cross-talk in order to both positively and negatively regulate each other. Because of its importance in cancer, the RAS-MAPK pathway targets have been a focus for drug targeting for last two decades. Rational therapies that target the key regulators of RAS pathway might inhibit tumor growth, survival and spread. See Mendoza MC; Er EE; Blenis I; Trends Biochem Sci. 2011 Jun; 36(6):320-8.
[0005] A major limitation in the detection and quantitation of RAS-RAF-MAPK pathway proteins is the lack of rigorously validated methods and reagents. Currently, only semi-quantitative results from Western blotting, ELISA, and Luminex assays are available. Mass spectrometry (MS) is increasingly becoming the detection methodology of choice for assaying protein abundance and post-translational modifications. However, to date, MS has not been successful in quantifying RAS-RAF-MAPK pathway proteins, possibly due to their low abundance and significant post-translational modification profiles.
[0006] Immunoenrichment or Immunoprecipitation (IP) is commonly used upstream of
MS as an enrichment tool for low-abundant protein targets. See, Gingras et al, Nat. Rev. Mol. Cell. Biol , Aug 2007, 8 (8), 645-54; and Carr, S. A. et al, Mol. Cell. Proteomics Mar 2014, 13 (3), 907-17. The identification of appropriate antibodies for use in IP upstream of MS is important, as not all antibodies that bind to protein will be effective immunoprecipitation tools, and further, not all antibodies that are effective immunoprecipitation tools will lead to successful identification via MS.
SUMMARY
[0007] The present disclosure provides reagents and methods for detecting and quantifying RAS-RAF-MAPK pathway proteins via immunoprecipitation (IP), mass spectrometry (MS), and immunoprecipitation followed by mass spectrometry (IP-MS).
[0008] In some embodiments, methods for immunoprecipitating a RAS-RAF-MAPK pathway protein are provided, comprising contacting a biological sample with any one of the antibodies recited in Table 1. In some embodiments, the antibodies useful in the IP methods comprise the antibodies recited in Table 6. The methods may comprise washing the contacted biological sample to enrich for antibody-protein conjugates. Further methods include detecting the antibody-protein conjugates to determine the RAS-RAF-MAPK pathway protein in the biological sample. In some embodiments, the antibody is labelled. In some embodiments, a detection reagent is provided to the enriched antibody-protein conjugate. In some embodiments the label is biotin and the detection reagent is streptavidin.
[0009] In some embodiments the IP is single-plex. In some embodiments the IP is multi-plex. The antibodies useful in multi-plex IP may comprise the antibodies of Table 6.
[0010] In some embodiments a method for detecting RAS-RAF-MAPK pathway proteins via MS is provided, comprising isolating proteins from a biological sample, digesting the isolated proteins, assaying the digested proteins via mass spectrometry to determine the presence of a peptide for RAS-RAF-MAPK pathway protein(s), and determining the identity of one or more RAS-RAF-MAPK pathway protein(s) in the sample. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments, the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400.
[0011] In some embodiments a method for quantifying RAS-RAF-MAPK pathway proteins via MS is provided, comprising isolating proteins from a biological sample, digesting the isolated proteins, assaying the digested proteins via mass spectrometry to determine the presence of a peptide for RAS-RAF-MAPK pathway protein(s), and determining the quantity of one or more RAS-RAF-MAPK pathway protein(s) in the sample. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments, the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0012] In some embodiments a method for detecting RAS-RAF-MAPK pathway proteins via IP-MS is provided, comprising treating a biological sample with at least one antibody capable of immunoprecipitating RAS-RAF-MAPK target pathway protein(s) from a biological sample, digesting the isolated proteins, assaying the digested proteins via mass spectrometry to determine the presence of a peptide for RAS-RAF-MAPK pathway protein(s), and determining the identity of one or more RAS-RAF-MAPK pathway protein(s) in the sample. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide for RAS- RAF-MAPK pathway protein(s) consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0013] In some embodiments a method for quantifying RAS-RAF-MAPK pathway proteins via IP-MS is provided, comprising treating a biological sample with at least one antibody capable of immunoprecipitating RAS-RAF-MAPK target pathway protein(s) from a biological sample, digesting the isolated proteins, assaying the digested proteins via mass spectrometry to determine the presence of a peptide for RAS-RAF-MAPK pathway protein(s), and determining the quantity of one or more RAS-RAF-MAPK pathway protein(s) in the sample. In some embodiments, the peptide for RAS-RAF-MAPK pathway protein(s) comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide for RAS- RAF-MAPK pathway protein(s) consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0014] In some embodiments the RAS-RAF-MAPK pathway target protein is phosphorylated.
[0015] Methods for determining the ratio of phosphorylated to non-phosphorylated
RAS-RAF-MAPK pathway proteins are provided, comprising any of the above IP, MS, or MS- IP methods, wherein a further step of determining the ratio of phosphorylated to non- phosphorylated protein is provided. In some embodiments, the method is an MS-IP method comprising treating a biological sample with one or more antibodies capable of
immunoprecipitating one or more phosphorylated RAS-RAF-MAPK pathway proteins, and separately treating the same biological sample with one or more antibodies capable of immunoprecipitating at least one or more of the same or different non-phosphorylated RAS- RAF-MAPK pathway proteins; digesting the immunoprecipitated RAS-RAF-MAPK pathway proteins; adding a first and a second detectably labelled internal standard peptide of known amount to the digested proteins, wherein the first internal standard peptide has the same amino acid sequence as a phosphorylated RAS-RAF-MAPK pathway peptide used to identify the phosphorylated protein, and the second internal standard peptide has the same amino acid sequence as the non-phosphorylated RAS-RAF-MAPK pathway peptide used to identify the non-phosphorylated protein; assaying the digested protein and internal standards via mass spectrometry to determine the presence and amount of phosphorylated and non-phosphorylated RAS-RAF-MAPK pathway proteins, wherein the RAS-RAF-MAPK pathway peptide comprises a peptide of SEQ ID NO: 1 - SEQ ID NO: 1400, and is less than or equal to 40 amino acids in length; determining the quantity of RAS-RAF-MAPK phosphorylated and non- phosphorylated pathway proteins in the sample, and determining the ratio of phosphorylated to non-phosphorylated pathway proteins. In some embodiments, the peptide for RAS-RAF- MAPK pathway protein(s) consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0016] In some embodiments, the biological sample is human. In some embodiments, the biological sample is non-human. In some embodiments, the biological sample is mammalian. In some embodiments, the biological sample is from rat, mouse, guinea pig, hamster, cow, pig, horse, goat, sheep, dog, cat, or non-human primate.
[0017] In embodiments utilizing a RAS-RAF-MAPK pathway peptide, the peptide may be modified with a detectable label. The detectable label may comprise an isotope, such as a heavy isotope, such as those known to those of skill in the art, including 1 C, 15 N, 2 H and 18 0. In some embodiments, the modified/labelled peptide comprises a peptide of SEQ ID NO: 701- 1400. In some embodiments the peptide is less than or equal to 40 amino acids in length. In some embodiments the modified/labelled peptide consists of a peptide of SEQ ID NO: 701- 1400. In some embodiments the modified/labelled peptide consists of a peptide of SEQ ID NO: 701-1400, wherein the peptide is further modified.
[0018] In some embodiments, the antibody for IP is chosen from the antibodies recited in Table 1. In some embodiments, the antibody for IP is an antibody having the six CDRs of any of the antibodies of Table 1. The antibody may be capable of immunoprecipitating more than one RAS-RAF-MAPK pathway protein. In some embodiments the antibody is labelled or capable of being labelled. The label may be any label known to those of skill in the art including enzymatic and fluorescent labels, such as biotin. In some embodiments more than one antibody is used in a multi-plex IP. In some embodiments, the multi-plex IP comprises the antibodies of Table 6. In some embodiments, the antibodies for multi-plex IP is an antibody having the six CDRs of any of the antibodies in Table 6. [0019] In some embodiments, two or more antibodies are utilized to analyze one biological sample. For example, a first antibody is capable of immunoprecipitating a phosphorylated RAS-RAF-MAPK pathway protein, and a second antibody is capable of immunoprecipitating a nonphosphorylated version of the RAS-RAF-MAPK pathway protein precipitated by the first antibody. In such an instance, a single biological sample may be divided into two aliquots and the first antibody used to immunoprecipitate the first aliquot and the second antibody used to immunoprecipitate the second aliquot. This is appropriate when the second antibody can precipitate both the phospohorylated and non-phosphorylated versions of the RAS-RAF-MAPK protein; it is also appropriate if the second antibody can only precipitate the non-phosphorylated versions. In another instance, the phosphorylated version of the RAS-RAF-MAPK pathway protein may be immunoprecipitated from the sample first (using the first antibody) and evaluated, and then in a later step the non- phosphorylated RAS- RAF-MAPK pathway protein may be immunoprecipitated (using the second antibody) and evaluated. This approach is appropriate if the second antibody can precipitate both the phosphorylated and non-phosphorylated versions of the RAS-RAF-MAPK protein. In some embodiments, a single antibody is capable of immunoprecipitating a phosphorylated and non- phosphorylated RAS-RAF-MAPK pathway protein.
[0020] In some embodiments, the immunoprecipitation comprises treating a sample with a labelled antibody capable of binding to a RAS-RAF-MAPK pathway protein to provide a labelled antibody-protein conjugate. The method may further comprise contacting the labelled antibody-protein conjugate with a capture agent capable of binding to the labelled antibody to isolate the pathway protein from the sample. The label may be biotin and the capture agent may be streptavidin.
[0021] The quantity of a RAS-RAF-MAPK pathway protein may be determined by adding an internal standard peptide of known amount to the digested protein prior to mass spectrometry. In some embodiments, the internal standard peptide has the same amino acid sequence as the RAS-RAF-MAPK pathway peptide. In some embodiments, the internal standard is detectably labeled. The method may further comprises determining the quantity of a RAS-RAF-MAPK pathway peptide by comparison to the internal standard.
[0022] In some embodiments, the internal standard peptide comprises a sequence of
SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0023] In some embodiments, quantifying the RAS-RAF-MAPK pathway protein comprises comparing an amount of a RAS-RAF-MAPK pathway peptide in the sample to an amount of the same RAS-RAF-MAPK pathway peptide in a control sample.
[0024] Quantifying a RAS-RAF-MAPK pathway protein may comprise comparing an amount of a RAS-RAF-MAPK pathway peptide to an internal standard peptide of known amount, wherein both the peptide in the biological sample and the internal standard peptide comprise SEQ ID NO: 1-SEQ ID NO: 1400, wherein the standard peptide is detectably labeled, and wherein the peptide is less than or equal to 40 amino acids long. In some embodiments, the standard peptide consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0025] In some embodiments the mass spectrometry is selected from tandem mass spectrometry and discovery mass spectrometry. The targeted mass spectrometry may be selected from multiple reaction monitoring (MRM), selected reaction monitoring (SRM), and parallel reaction monitoring (PRM), or combinations thereof.
[0026] In some embodiments the biological sample is selected from isolated human cells, plasma, serum, whole blood, CSF, urine, sputum, tissue, and tumorous tissue.
[0027] In some embodiments, the method further comprises quantifying the relative amount of RAS-RAF-MAPK pathway protein. In some embodiments, the method further comprises quantifying the absolute amount of RAS-RAF-MAPK pathway protein.
[0028] In some embodiments, the digesting comprises a protease or chemical digest. In some embodiments the digestion may be single or sequential. The protease digestion may comprise trypsin, chymotrypsin, AspN, GluC, LysC, LysN, ArgC, proteinase K, pepsin, clostripain, elastase, GluC biocarb, LysC/P, LysN promise, protein endopeptidase, staph protease or thermolysin.
[0029] The chemical cleavage may comprise CNBr, iodosobenzoate or formic acid.
[0030] In some embodiments the digestion is a protease digest with trypsin.
[0031] In some embodiments the methods further comprise desalting after digestion and prior to mass spectrometry.
[0032] The RAS-RAF-MAPK pathway protein may be chosen from proteins listed in
Table 4
[0033] In some embodiments, the RAS-RAF-MAPK pathway protein is
phosphorylated.
[0034] In some embodiments, the concentration of RAS-RAF-MAPK protein that may be detected ranges from about 0.04 fmol to about 2000 fmol.
[0035] In some embodiments, the lower limit of detection is no more than about 0.04,
0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.20, 0.21, 0.22, 0.23, 0.24, or 1.23 fmol. The lower limit of detection may be from of about 0.04 - 1.23 fmol.
[0036] In some embodiments the lower limit of quantification is no more than about
0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.20, 0.21, 0.22, 0.23, 0.24, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50, 0.55, 0.60, 0.65, 0.70, or 11.11 fmol. The lower limit of quantification may be from about 0.04 - 11.11 fmol.
[0037] Kits comprising one or more antibodies capable of immunoprecipitating a RAS-
RAF-MAPK pathway protein are encompassed.
[0038] Kits comprising one or more antibodies capable of immunoprecipitating a RAS-
RAF-MAPK pathway protein, and reagents useful for performing mass spectrometry to detect a RAS-RAF-MAPK pathway protein are also provided.
[0039] Also encompassed are kits comprising one or more antibodies capable of immunoprecipitating a RAS-RAF-MAPK pathway target protein, and reagents useful for performing mass spectrometry to quantify a RAS-RAF-MAPK pathway protein.
[0040] The antibody to be included in the kit may be selected from any one or more of the antibodies recited in Table 1. In some embodiments the antibody is labelled or capable of being labelled. The label may be any label known to those of skill in the art including enzymatic and fluorescent labels, such as biotin. In some embodiments, the kit comprises more than one antibody. In some embodiments, the kit comprises two or more of the antibodies selected from the antibodies recited in Table 6. [0041] The kits may further comprise a RAS-RAF-MAPK pathway peptide. In some embodiments, the peptide comprises a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. In some embodiments the peptide is less than or equal to 40 amino acids in length. In some embodiments, the peptide consists of a sequence of SEQ ID NO: 1 - SEQ ID NO: 1400. The peptides of SEQ ID NO: 1 - SEQ ID NO: 700 may be labelled. In some embodiments the label on SEQ ID NO: 1 - SEQ ID NO: 700 differs from the label shown on the peptides of SEQ ID NO: 701 - SEQ ID NO: 1400. In some embodiments, the peptide comprises or consists of a peptide selected from the peptides shown in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699).
[0042] In some embodiments, the kit may comprise at least one peptide selected from peptides of SEQ ID NO: 701 - SEQ ID NO: 1400, wherein the peptide is less than or equal to 40 amino acids. In one embodiment, the kit comprises at least one peptide consisting of SEQ ID NO: 701 - SEQ ID NO: 1400.
[0043] The peptides provided in the kit may be detectably labeled or capable of being modified to be detectably labeled. In some embodiments, the kit may comprise at least one peptide selected from peptides of SEQ ID NO: 1 - SEQ ID NO: 700, wherein the peptide is detectably labeled or capable of being modified to be detectably labeled.
[0044] In some embodiments, the kit further comprises a protease or chemical agent capable of digesting an immunoprecipitated protein sample. The protease agent may be trypsin, chyniotrypsin, AspN, GluC, LysC, LysN, ArgC, proteinase K, pepsin, clostripain, elastase, GluC biocarb, LysC/P, LysN promise, protein endopeptidase, Staph protease or thermolysin. The chemical agent may be CNBr, iodosobenzoate or formic acid.
[0045] In some embodiments, the kit may comprise some or all of the following items: single or multiple biotinylated antibody mix, streptavidin magnetic beads (such as Pierce Strepavidin Magnetic Beads), IP-MS cell lysis buffer, IP-MS wash buffer(s), IP-MS elution buffer, positive control lysates, low binding tubes, reduction/alkylation reagents for MS sample prep, digestion buffer for MS sample prep, trypsin, buffer to stop trypsin digestion (such as 10% trifiuoroacetic acid), AQUA (Absolute QUAntification) heavy peptide mix, diluent for peptides (such as 0.1% trifiuoroacetic acid/5% acetonitrile), matrix (light crude peptides spiked into 6 proteins digest mix), and memory device (such as a USB stick) including the instrument method, skyline software template, and instructions. [0046] The kits may be utilized to detect RAS-RAF-MAPK pathway proteins listed in
Table 4
[0047] The RAS-RAF-MAPK protein to be detected and quantified by the kits may be phosphorylated.
BRIEF DESCRIPTION OF THE FIGURES
[0048] FIGURE 1 shows one representative workflow for an immunoprecipitation- enriched mass spectrometry assay to identify RAS-RAF-MAPK pathway proteins.
[0049] FIGURE 2 shows results from an experiment to enrich for low abundant RAS-
RAF-MAPK pathway proteins from HCT116 or BT549 cells.
[0050] FIGURE 3 shows quantitation limits of peptides for RAS-RAF-MAPK pathway proteins.
[0051] FIGURE 4 shows the results of a multiplex immunoprecipitation plus nanoLC-
MS/MS assay for 12 RAS-RAF-MAPK pathway proteins panel 1.
[0052] FIGURE 5 shows the results of a multiplex immunoprecipitation plus nanoLC-
MS/MS assay for 12 RAS-RAF-MAPK pathway proteins panel 2.
[0053] FIGURE 6 shows the results of a multiplex immunoprecipitation plus nanoLC-
MS/MS assay for 13 RAS-RAF-MAPK pathway proteins Panel 3.
[0054] FIGURE 7 shows a summary of RAS-RAF-MAPK pathway proteins identified and quantified in HCT116 cell lines, with and without immunoprecipitation enrichment, using the mass spec methods.
DETAILED DESCRIPTION
[0055] This description and exemplary embodiments should not be taken as limiting.
For the purposes of this specification and appended claims, unless otherwise indicated, all numbers expressing quantities, percentages, or proportions, and other numerical values used in the specification and claims, are to be understood as being modified in all instances by the term "about," to the extent they are not already so modified. Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. [0056] It is noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the," and any singular use of any word, include plural referents unless expressly and unequivocally limited to one referent. As used herein, the term "include" and its grammatical variants are intended to be non-limiting, such that recitation of items in a list is not to the exclusion of other like items that can be substituted or added to the listed items.
[0057] As used herein, an "RAS-RAF-MAPK pathway protein" includes, but is not limited to, BRAF (UniProtKB - PI 5056), HRAS (UniProtKB - P01112), KRAS (UniProtKB P01116), NRAS (UniProtKB - P01111), MAP2K1 (UniProtKB - Q02750), MAP2K2 (UniProtKB - P36507), MAPK1 (UniProtKB - P28482), MAPK3 (UniProtKB - P27361), MAPK8
(UniProtKB - P45983), MAPK9 (UniProtKB - P45984), PIK3CA (UniProtKB - P42336), RPS6KA1 (also known as p90S6K) (UniProtKB - Q15418), and TP53 (UniProtKB - P04637).
[0058] As used herein "protein", "peptide", and "polypeptide" are used
interchangeably throughout to mean a chain of amino acids wherein each amino acid is connected to the next by a peptide bond. In some embodiments, when a chain of amino acids consists of about two to forty amino acids, the term "peptide" is used. However, the term "peptide" should not be considered limiting unless expressly indicated.
[0059] The term "antibody" is used in the broadest sense and encompasses various antibody structures, including but not limited to monoclonal antibodies, polyclonal antibodies, multispecific antibodies (such as bispecific antibodies), and antibody fragments so long as they exhibit the desired immunoprecipitating activity. As such, the term antibody includes, but is not limited to, fragments that are capable of binding to an antigen, such as Fv, single-chain Fv (scFv), Fab, Fab', di-scFv, sdAb (single domain antibody) and (Fab')2 (including a chemically linked F(ab')2). Papain digestion of antibodies produces two identical antigen-binding fragments, called "Fab" fragments, each with a single antigen-binding site, and a residual "Fc" fragment. Pepsin treatment yields a F(ab')2 fragment that has two antigen-binding sites. The term antibody also includes, but is not limited to, chimeric antibodies, humanized antibodies, and antibodies of various species such as mouse, goat, horse, sheep, chicken, etc. Furthermore, for all antibody constructs provided herein, variants having the sequences from other organisms are also contemplated, such as CDR-grafted antibodies or chimeric antibodies. Antibody fragments also include either orientation of single chain scFvs, tandem di-scFv, diabodies, tandem tri-sdcFv, minibodies, etc. Antibody fragments also include nanobodies (sdAb, an antibody having a single, monomelic domain, such as a pair of variable domains of heavy chains, without a light chain). An antibody fragment can be referred to as being a specific species in some embodiments (for example, human scFv or a mouse scFv). This denotes the sequences of at least part of the non-CDR regions, rather than the source of the construct. The antibodies are referred to by reference to name and catalog reference. The skilled artisan, holding this name and catalog information, is capable of determining the sequence of the antibody, and therefore this application encompasses any antibody having at least partial sequence of a reference antibody so long as the antibody maintains its ability to immunoprecipitate its antigen protein. In some embodiments, the antibodies comprise antibodies having the same CDRs as the antibodies provided in Table 1 or Table 6.
[0060] "Immunoprecipitate" or "immunoprecipitation" refers to any antibody-driven enrichment step, whether or not an actual precipitate is formed. Thus, immunoprecipitation includes any immunoenrichment step.
[0061] Mass spectrometry (MS) is a primary technique for analysis of proteins on the basis of their mass-to-charge ratio (m/z). MS techniques generally include ionization of compounds and optional fragmentation of the resulting ions, as well as detection and analysis of the m/z of the ions and/or fragment ions followed by calculation of corresponding ionic masses. A "mass spectrometer" generally includes an ionizer and an ion detector. "Mass spectrometry," "mass spec," "mass spectroscopy," and "MS" are used interchangeably throughout.
[0062] "Targeted mass spectrometry," also referred to herein as "targeted mass spec,"
"targeted MS," and "tMS" increases the speed, sensitivity, and quantitative precision of mass spec analysis. Non-targeted mass spectrometry, sometimes referred to as "data-dependent scanning," "discovery MS," and "dMS" and targeted mass spec are alike in that in each, analytes (proteins, small molecules, or peptides) are infused or eluted from a reversed phase column attached to a liquid chromatography instrument and converted to gas phase ions by electrospray ionization. Analytes are fragmented in the mass spec (a process known as tandem MS or MS/MS), and fragment and parent masses are used to establish the identity of the analyte. Discovery MS analyzes the entire content of the MS/MS fragmentation spectrum. In contrast, in targeted mass spectrometry, a reference spectrum is used to guide analysis to only a few selected fragment ions rather than the entire content.
[0063] "Multiple reaction monitoring," "MRM," "selected reaction monitoring," and
"SRM" are used interchangeably throughout to refer to a type of targeted mass spectrometry that relies on a unique scanning mode accessible on triple-quadrupole (QQQ) instruments. See, e.g., Chambers et al, Expert Rev. Proteomics, 1-12 (2014).
[0064] "Parallel Reaction Monitoring," and "PRM" are used interchangeably herein to describe another type of targeted mass spec wherein the second mass analyzer used in SRM (quadrupole) is substituted by a high resolution orbitrap mass analyzer in PRM. Unlike SRM, which allows the measuring of one single transition at a given point in time, PRM allows parallel monitoring in one MS/MS spectrum. PRM also allows for the separation of ions with close m/z values (i.e., within a 10 ppm range), and may therefore allow for lower limits of detection and quantification (LOD or LLOD and LOQ or LLOQ).
[0065] The methods disclosed herein may be applied to any type of MS analysis. The disclosure is not limited by the specific equipment or analysis used. The use of any equipment with the intent of analyzing the m/z of a sample would be included in the definition of mass spectrometry. Non-limiting examples of MS analysis and/or equipment that may be used include electrospray ionization, ion mobility, time-of-flight, tandem, ion trap, MRM, SRM, MRM/SRM, PRM, and Orbitrap. The disclosure is neither limited by the type of ionizer or detector used in the MS analysis nor by the specific configuration of the MS. The disclosure is not limited to use with specific equipment or software. The disclosure is not limited to the equipment and software described in the Examples.
[0066] In some embodiments, methods of immunoprecipitating a RAS-RAF-MAPK pathway protein are provided, comprising contacting a biological sample with at least one antibody recited in Table 1. The immunoprecipitating method may be single-plex or multiplex. A "single-plex" IP utilizes one antibody per assay, whereas a "multi-plex" IP utilizes more than one antibody per assay.
[0067] In some embodiments, an IP-MS method for detecting and quantifying phosphorylated and non-phosphorylated RAS-RAF-MAPK pathway proteins is provided. The methods may comprise contacting a biological sample with at least one antibody recited in Table 1, digesting the immunoprecipitated protein(s), and assaying the digested proteins via mass spectrometry. The IP and MS may be single-plex or multi-plex. A "single-plex" MS refers to monitoring a single peptide in a single MS run, whereas a "multi-plex" MS refers to monitoring more than one target peptides in a single MS run.
[0068] Table 1 provides a listing of antibodies useful in the IP and IP-MS methods.
Table 2 provides a listing of antibodies that are known to bind to their antigen RAS-RAF- MAPK protein, but were found to be less useful in the IP and IP-MS methods.
Table 1: List of IP to MS validated antibodies for RAS-RAF-MAPK Pathway Proteins
ALK Antibody Thermo Fisher Scientific/35-4300
ALK Antibody Thermo Fisher Scientific/51-3900
ARAF Antibody Thermo Fisher Scientific/PA 1-21440
ARAF Antibody Thermo Fisher Scientific/PA5-17657
BRAF Antibody Cell Signaling Technology/14814S
BRAF Antibody Thermo Fisher Scientific/PA5- 14926
BRAF Antibody Thermo Fisher Scientific/PA5- 14929
BRAF Antibody Thermo Fisher Scientific/MA5-15000
CALM1 Antibody Millipore/05-173
CAMK2A Antibody Thermo Fisher Scientific/PA5- 17095
CCND1 Antibody Thermo Fisher Scientific/MAl-34820
CCND1 Antibody Thermo Fisher Scientific/PA 1-37530
CCND1 Antibody Thermo Fisher Scientific/MA5-14512
Cyclin Dl Antibody Cell Signaling Technology /2922S
Cyclin Dl Antibody Millipore/ABE52
Cyclin Dl Antibody Thermo Fisher Scientific/MAl-12296
Cyclin Dl Antibody Thermo Fisher Scientific/PAl-29132
Cyclin Dl Antibody Thermo Fisher Scientific/MAl-26755
Cyclin Dl Antibody Thermo Fisher Scientific/AHF0082
Cyclin Dl Antibody Thermo Fisher Scientific/33-3500
Cyclin Dl Antibody Thermo Fisher Scientific/PA5-32373
Cyclin Dl / Bel- 1 Antibody Thermo Fisher Scientific/PA5-16232
CDH1 Antibody Cell Signaling Technology/14472S
CDH1 Antibody Thermo Fisher Scientific/13-5700
CDH1 Antibody Thermo Fisher Scientific/13-1700
CDH1 Antibody Thermo Fisher Scientific/33-4000
CDH1 Antibody Thermo Fisher Scientific/PA5-32282
CDH1 Antibody Thermo Fisher Scientific/PA5-32178
CDH1 Antibody Thermo Fisher Scientific/MAl-06300
CDH1 Antibody Thermo Fisher Scientific/MA5-14458
CDH1 Antibody Thermo Fisher Scientific/MA5- 12547
CDH2 Antibody Thermo Fisher Scientific/PAl-20359
CDH2 Antibody Thermo Fisher Scientific/MAl-159
CDH2 Antibody Thermo Fisher Scientific/MA5-16324
CDK2 Antibody Thermo Fisher Scientific/MA5-13725
CDK2 Antibody Thermo Fisher Scientific/AHZ0142
CDKNlA/p21 Antibody Cell Signaling Technology /883 IS
CDKNlA/p21 Antibody Millipore/05-655
CDKNlA/p21 Antibody Millipore/05-345
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5 -25960
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5- 12644
CDKNlA/p21 Antibody Thermo Fisher Scientific/MA5- 14949
CDKNlA/p21 Antibody Thermo Fisher Scientific/MAl-4800
CDKNlA/p21 Antibody Thermo Fisher Scientific/MAl- 12303
CDKNlA/p21 Antibody Thermo Fisher Scientific/MAl -19271
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA 1-30399 CDKNlA/p21 Antibody Thermo Fisher Scientific/MA 1-91243
CDKNlA/p21 Antibody Thermo Fisher Scientific/MAl-33926
CDKNlA/p21 Antibody Thermo Fisher Scientific/AHZ0422
CDKNlA/p21 Antibody Thermo Fisher Scientific/710182
CDKNlA/p21 Antibody Thermo Fisher Scientific/701151
CDKN1B Antibody Cell Signaling Technology /3688S
CDKN1B Antibody Thermo Fisher Scientific/PA5-18480
CDKN1B Antibody Thermo Fisher Scientific/PA5- 17946
CDKN1B Antibody Thermo Fisher Scientific/PA5-27188
CDKN1B Antibody Thermo Fisher Scientific/PA5-16717
CDKN1B Antibody Thermo Fisher Scientific/PA5-32530
CDKN1B Antibody Thermo Fisher Scientific/PAl-38351
CDKN2A/p 14ARF Antibody Abcam/ab 11048
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-31409
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/MAl-20219
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/MA5- 14260
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-46021
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-16662
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-16639
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PA5-32529
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-38334
CDKN2A/pl6INK4a Antibody Abcam/abl6123
CDKN2A/pl6INK4a Antibody Abcam/abl25282
CDKN2A/pl6INK4a Antibody Thermo Fisher Scientific/PA 1-9025
CDKN2A/pl6INK4a Antibody Thermo Fisher Scientific/PA5-20379
CTNNA1 Antibody Thermo Fisher Scientific/MAl-2000
CTNNAl Antibody Thermo Fisher Scientific/ 13 -9700
CTNNBl Antibody Cell Signaling Technology /9582S
CTNNBl Antibody Cell Signaling Technology/8814S
CTNNBl Antibody Thermo Fisher Scientific/PA5- 19469
CTNNBl Antibody Thermo Fisher Scientific/MAl-10056
CTNNBl Antibody Thermo Fisher Scientific/MAl-34999
CTNNBl Antibody Thermo Fisher Scientific/PA5- 16762
CTNNBl Antibody Thermo Fisher Scientific/PA5- 16429
CTNNBl Antibody Thermo Fisher Scientific/MA 1-301
CTNNBl Antibody Thermo Fisher Scientific/MAl-300
CTNNBl Antibody Thermo Fisher Scientific/MA 1-2001
CTNNBl Antibody Thermo Fisher Scientific/13-8400
CTNNBl Antibody Thermo Fisher Scientific/71-2700
CTNNBl Antibody Thermo Fisher Scientific/44206M
CTNNBl Antibody Thermo Fisher Scientific/PAl-37255
CTNNBl Antibody Thermo Fisher Scientific/MA5- 14461
DDR2 Antibody Cell Signaling Technology/12133S
DUSP22 Antibody Thermo Fisher Scientific/PA5-33488
DUSP4 Antibody Cell Signaling Technology/5149
DUSP4 Antibody Thermo Fisher Scientific/PA5- 15549 DUSP6 Antibody Thermo Fisher Scientific/PA5-21570
DUSP6 Antibody Thermo Fisher Scientific/PA5-17107
EGFR Antibody Thermo Fisher Scientific/MA5-13697
EGFR Antibody Thermo Fisher Scientific/MA5-13319
EGFR Antibody Thermo Fisher Scientific/MA5- 13269
EGFR Antibody Thermo Fisher Scientific/MA5-13070
EGFR Antibody Thermo Fisher Scientific/MA5-13048
EGFR Antibody Thermo Fisher Scientific/MA5- 12880
EGFR Antibody Thermo Fisher Scientific/MA5-12875
EGFR Antibody Thermo Fisher Scientific/PAl-1110
EGFR Antibody Thermo Fisher Scientific/700308
EGFR Antibody Thermo Fisher Scientific/700994
EGFR Antibody Thermo Fisher Scientific/MA5-13877
EGFR Antibody Thermo Fisher Scientific/MA5- 13343
EGFR Antibody Thermo Fisher Scientific/MA5- 14485
EIF2A Antibody Proteintech/11233-1-AP
EIF2A Antibody Abcam/ab 102786
EIF2A Antibody Thermo Fisher Scientific/PA5-34795
EIF4E Antibody Cell Signaling Technology /9742S
EIF4E Antibody Thermo Fisher Scientific/PA5-11797
EIF4E Antibody Thermo Fisher Scientific/MAl-089
EIF4EBP1 Antibody Cell Signaling Technology /9644S
EIF4EBP1 Antibody Cell Signaling Technology /4923S
EIF4EBP1 Antibody Thermo Fisher Scientific/PA5-11830
EIF4EBP1 Antibody Thermo Fisher Scientific/PA5 -28947
EIF4EBP1 Antibody Thermo Fisher Scientific/PA5-20135
ERBB3 Antibody Cell Signaling Technology/12708S
ERBB3 Antibody Thermo Fisher Scientific/PA 1-30497
ERBB3 Antibody Thermo Fisher Scientific/MA5-13053
ERBB3 Antibody Thermo Fisher Scientific/MA5- 13040
ERBB3 Antibody Thermo Fisher Scientific/MA5- 12867
ERBB3 Antibody Thermo Fisher Scientific/MA5- 12675
ERBB3 Antibody Thermo Fisher Scientific/MA5-16349
ERBB3 Antibody Thermo Fisher Scientific/PAl -86644
ERBB3 Antibody Thermo Fisher Scientific/PA 1-9040
ERBB3 Antibody Thermo Fisher Scientific/PA5-32346
ERBB4 Antibody Cell Signaling Technology /4795S
ERBB4 Antibody Thermo Fisher Scientific/PAl -20922
ERBB4 Antibody Thermo Fisher Scientific/MA5- 12888
ERBB4 Antibody Thermo Fisher Scientific/PA5- 16642
ERBB4 Antibody Thermo Fisher Scientific/PA5-32347
ESR1 Antibody Cell Signaling Technology /8644S
ESR1 Antibody Millipore/06-935
ESR1 Antibody Thermo Fisher Scientific/MAl-12692
ESR1 Antibody Thermo Fisher Scientific/MAl-23214
ESR1 Antibody Thermo Fisher Scientific/MA 1-25623 ESR1 Antibody Thermo Fisher Scientific/PAl-309
ESR1 Antibody Thermo Fisher Scientific/MA5-13065
ESR1 Antibody Thermo Fisher Scientific/PA5- 16440
ESR1 Antibody Thermo Fisher Scientific/MA5-13191
ESR1 Antibody Thermo Fisher Scientific/MA5- 13304
ESR1 Antibody Thermo Fisher Scientific/PA5-32397
FBX07 Antibody Novus Bio/NBPl-55051
FBX07 Antibody Millipore/ABN1038
FBX07 Antibody Millipore/MABN447
FBX07 Antibody Thermo Fisher Scientific/PA5-42300
FBX07 Antibody Thermo Fisher Scientific/PA5-27589
FGFR1 Antibody Cell Signaling Technology /9740S
FGFR1 Antibody Thermo Fisher Scientific/PA5-14650
FGFR1 Antibody Thermo Fisher Scientific/PA5- 14648
FGFR3 Antibody Thermo Fisher Scientific/MA5- 14843 c-Fos Antibody Thermo Fisher Scientific/PA5- 17489 c-fos Antibody Thermo Fisher Scientific/MA5-15055 c-Fos Antibody Thermo Fisher Scientific/MAl-21190 c-Fos Antibody Thermo Fisher Scientific/38-4950 c-Fos Antibody Thermo Fisher Scientific/PAl-37437
FOXOl Antibody Thermo Fisher Scientific/82358
FOXOl Antibody Thermo Fisher Scientific/MA5-14846
FOXOl Antibody Thermo Fisher Scientific/PA5-18696
FOXOl Antibody Thermo Fisher Scientific/PA5-32412
FOX03 Antibody Cell Signaling Technology/12829S
FOX03 Antibody Thermo Fisher Scientific/PA5-19519
FOX03 Antibody Thermo Fisher Scientific/PA 1-9042
FOX03 Antibody Thermo Fisher Scientific/PA 1-31322
FOX03 Antibody Thermo Fisher Scientific/PAl-805
FOX03 Antibody Thermo Fisher Scientific/PA5-23191
FOX03 Antibody Thermo Fisher Scientific/PA5-32413
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/PAl-12361
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/PA 1-37426
HER-2 / ErbB2 Antibody Antibody Thermo Fisher Scientific/PA5-16305
HER-2 / ErbB2 Antibody (3B5) Antibody Thermo Fisher Scientific/MA5-13675
HER-2 / ErbB2 Antibody (9G6.10) Antibody Thermo Fisher Scientific/MA5- 12759
HER-2 / ErbB2 Antibody (e2-4001 + 3B5) Thermo Fisher Scientific/MA5-14057
Antibody
HER-2 / ErbB2 Antibody (K.929.9) Antibody Thermo Fisher Scientific/MA5-15050
HER-2 / ErbB2 Antibody (L26) Antibody Thermo Fisher Scientific/MA5-13679
HER-2/ERBB-2 Antibody Thermo Fisher Scientific/MAl-12691
HER-2/ERBB-2 Antibody Thermo Fisher Scientific/AHOlOl l
IQGAP1 Antibody Abcam/ab33542
IQGAP1 Antibody Thermo Fisher Scientific/33-8900
JAK1 Antibody Cell Signaling Technology /3332S
JAK1 Antibody Cell Signaling Technology /3344S JAK2 Antibody Cell Signaling Technology /323 OS
JAK2 Antibody Thermo Fisher Scientific/ AH01352
JAK2 Antibody Thermo Fisher Scientific/44-406G
MAP2K1 Antibody Thermo Fisher Scientific/MA5-15093
MAP2K1 Antibody Thermo Fisher Scientific/PAl -29035
MAP2K2 Antibody Abcam/ab28834
MAP2K2 Antibody Thermo Fisher Scientific/PA5- 17678
MAP2K2 Antibody Thermo Fisher Scientific/PA5-27635
MAPK1 Antibody Thermo Fisher Scientific/PAl -37640
MAPK1 Antibody Thermo Fisher Scientific/PA5-32396
MAPK1 Antibody Abcam/ab7948
MAPK1 Antibody Thermo Fisher Scientific/PAl -30388
MAPK1 Antibody Thermo Fisher Scientific/PAl -21016
MAPK1/3 Antibody Proteintech/66192-l-Ig
MAPK11 Antibody Abcam/ab80116
MAPK8 Antibody Thermo Fisher Scientific/LF-PA0047
MAPK8 Antibody Thermo Fisher Scientific/35-9800
MAPK9 Antibody Thermo Fisher Scientific/PA5 -28664
MAPK9 Antibody Thermo Fisher Scientific/PA5- 17634
MAPK9 Antibody Thermo Fisher Scientific/MA 1-21411
MET Antibody Cell Signaling Technology /8198S
MET Antibody Thermo Fisher Scientific/PA5-17148
MET Antibody Thermo Fisher Scientific/MA5- 14847
MET Antibody Thermo Fisher Scientific/PA5-27235
MET Antibody Thermo Fisher Scientific/PAl -29042
MET Antibody Thermo Fisher Scientific/PAl -28026
MET Antibody Thermo Fisher Scientific/71-8000
MET Antibody Thermo Fisher Scientific/37-0100
MET Antibody Thermo Fisher Scientific/18-7366
MET Antibody Thermo Fisher Scientific/700261
MET Antibody Thermo Fisher Scientific/PA5-32357
MTOR Antibody Thermo Fisher Scientific/ PA1-188
MTOR Antibody Thermo Fisher Scientific/ PA1-518
NF1 Antibody Abcam/ab 17963
NF1 Antibody Millipore/05-1430
NF1 Antibody Millipore/07-730
NF1 Antibody Thermo Fisher Scientific/PAl -46246
NOTCH 1 Antibody Cell Signaling Technology /3608S
NOTCH 1 Antibody Thermo Fisher Scientific/41-3500
NOTCH 1 Antibody Thermo Fisher Scientific/PA5-32522
PAK1 Antibody Thermo Fisher Scientific/PA5- 17798
PAK1 Antibody Thermo Fisher Scientific/71-9300
PAK1,2,3 Antibody Thermo Fisher Scientific/PA5- 17789 pan MAPK8/9 Antibody Proteintech/51153-l-AP
pan MAPK8/9 Antibody Thermo Fisher Scientific/AH01362
Pan-Cadherin Antibody Thermo Fisher Scientific/PA5-17526 Pan-Cadherin Antibody Thermo Fisher Scientific/MA5-15036
Pan-Cadherin Antibody Thermo Fisher Scientific/PA5- 16766
Pan-Cadherin Antibody Thermo Fisher Scientific/PA5- 16481
Pan-Cadherin Antibody Thermo Fisher Scientific/71-7100
Pan-Cadherin Antibody Thermo Fisher Scientific/PAl-37199
PARP1 Antibody Thermo Fisher Scientific/MA5-15031
PARP1 Antibody Thermo Fisher Scientific/PA5-16561
PGR Antibody Cell Signaling Technology /8757S
PGR Antibody Thermo Fisher Scientific/MAl-12626
PGR Antibody Thermo Fisher Scientific/MA5-12658
PGR Antibody Thermo Fisher Scientific/MA5- 12642
PGR Antibody Thermo Fisher Scientific/PA5- 16709
PGR Antibody Thermo Fisher Scientific/MAl-411
PGR Antibody Thermo Fisher Scientific/MA5-14842
PGR Antibody Thermo Fisher Scientific/PA 1-38491
PGR Antibody Thermo Fisher Scientific/PA5-17180
PGR Antibody Thermo Fisher Scientific/MA5- 14841
PI3KCA Antibody Millipore/09-481
PI3KCA Antibody Millipore/07-658
PI3KCA Antibody Thermo Fisher Scientific/MA5- 14870
PIK3R2 Antibody Thermo Fisher Scientific/MAl-90048
PSMG1 Antibody Cell Signaling Technology/13378S
PSMG1 Antibody Abcam/ab83527
PSMG1 Antibody Thermo Fisher Scientific/PA5- 19076
RAF1 Antibody Millipore/07-396
RAF1 Antibody Thermo Fisher Scientific/PA5 -28652
RAF1 Antibody Thermo Fisher Scientific/MA5- 17162
Ras- pan Antibody Thermo Fisher Scientific/MAl-012
RASA1 Antibody Abcam/ab2922
RASA1 Antibody Millipore/06-157
RASA1 Antibody Thermo Fisher Scientific/MA4-001
RASGRF1 Antibody Proteintech/12958-l-AP
RASGRF2 Antibody Origene/TA590561
RASGRF2 Antibody Abcam/abl21577
Ras-N Antibody Cell Signaling Technology /3965S
Ras-N Antibody Thermo Fisher Scientific/PA5- 18888
Ras-N Antibody Thermo Fisher Scientific/PA5-34560
Ras-v-H Antibody Thermo Fisher Scientific/33-7200
RICTOR Antibody Cell Signaling Technology /9476S
RICTOR Antibody Abcam/ab70373
RICTOR Antibody Thermo Fisher Scientific/PA5-14107
RICTOR Antibody Thermo Fisher Scientific/PA5- 17451
RICTOR Antibody Thermo Fisher Scientific/MA5-15006
RICTOR Antibody Thermo Fisher Scientific/PA5-18370
RICTOR Antibody Thermo Fisher Scientific/PA5-21582
RICTOR Antibody Thermo Fisher Scientific/PAl-41209 RPS6KB2 Antibody Cell Signaling Technology/14130S
RPS6KB2 Antibody Abcam/abl31526
RPS6KB2 Antibody Abcam/ab76960
RPS6KB2 Antibody Abcam/ab37699
RPS6KB2 Antibody Thermo Fisher Scientific/PA5- 15234
Raptor Antibody Millipore/09-217
Raptor Antibody Cell Signaling Technology /2280S
Raptor Antibody Millipore/05-1470
Raptor Antibody Thermo Fisher Scientific/42-4000
Raptor Antibody Thermo Fisher Scientific/PA5-20125
RSK1 (RPS6KA1) Antibody Cell Signaling Technology /8408S
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-23665
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-17168
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-29215
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-21699
RSK2 (RPS6KA3) Antibody Millipore/06-918
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/PA5- 17169
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/PA5-29214
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/38-6800
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/PAl-4694
RSK2 + RSK3 Antibody Thermo Fisher Scientific/MA5-17212
SMAD3 Antibody Thermo Fisher Scientific/51-1500
SMAD4 Antibody R&D Systems/AF2097-SP
SMAD4 Antibody Thermo Fisher Scientific/PA5- 14845
SMAD4 Antibody Thermo Fisher Scientific/PA5-16191
SMAD4 Antibody Thermo Fisher Scientific/PA5-34806
SMAD4 Antibody Thermo Fisher Scientific/PAl-31458
SMAD4 Antibody Thermo Fisher Scientific/MA5- 14300
SMAD4 Antibody Thermo Fisher Scientific/701682
SOS1 Antibody Cell Signaling Technology/12409
SOS1 Antibody Cell Signaling Technology /5890S
SOS1 Antibody Millipore/07-337
SPRED1 Antibody Millipore/ABS186
SPRED1 Antibody Genetex/GTX85376
SPRED1 Antibody Thermo Fisher Scientific/PA5-20618
SPRED1 Antibody Thermo Fisher Scientific/PA5-20617
SPRED2 Antibody Millipore/ABS198
SPRY1 Antibody Cell Signaling Technology/13013S
SPRY1 Antibody Thermo Fisher Scientific/PA5- 18289
SPRY1 Antibody Thermo Fisher Scientific/40- 1800
SPRY2 Antibody Millipore/07-524
SPRY2 Antibody Cell Signaling Technology/14954S
SPRY3 Antibody LifeSpan BioSciences/LS-C335646
SPRY4 Antibody Abcam/ab82298
SPRY4 Antibody Thermo Fisher Scientific/PA5 -26959
SPRY4 Antibody Thermo Fisher Scientific/PA5-14349 STAT1 Antibody Thermo Fisher Scientific/AHO0832
STAT3 Antibody Cell Signaling Technology /9139S
STAT3 Antibody Thermo Fisher Scientific/PA5-18562
STAT3 Antibody Thermo Fisher Scientific/PAl-9105
STAT3 Antibody Thermo Fisher Scientific/MAl-13042
STAT3 Antibody Thermo Fisher Scientific/13-7000
STK11 Antibody Thermo Fisher Scientific/MA5- 14942
TP53 Antibody Thermo Fisher Scientific/MAl-12648
TP53 Antibody Thermo Fisher Scientific/MAl-12549
TP53 Antibody Thermo Fisher Scientific/MAl-19055
TP53 Antibody Thermo Fisher Scientific/MA5- 15244
TP53 Antibody Thermo Fisher Scientific/MA5-14067
TP53 Antibody Thermo Fisher Scientific/MA5-12453
TP53 Antibody Thermo Fisher Scientific/MA5-11296
TP53 Antibody Thermo Fisher Scientific/AHO0152
TP53 Antibody Thermo Fisher Scientific/MA5-12557
TP53 Antibody Thermo Fisher Scientific/ 13 -4100
TP53 Antibody Thermo Fisher Scientific/13-4000
TP53 Antibody Thermo Fisher Scientific/49-1031
TP53 Antibody Thermo Fisher Scientific/MA5-14467
TP53 Antibody Thermo Fisher Scientific/MA5-14516
Phospho-TP53 (pSerl5) Antibody Thermo Fisher Scientific/700439
Phospho-TP53 (pSerl5) Antibody Thermo Fisher Scientific/MA5- 15229
Phospho-MAPKl/3 (pThr202/pTyr204) Thermo Fisher Scientific/MA5-15173
Antibody
Phospho-MAPKl/3 (pThr202/pTyr204) Thermo Fisher Scientific/PAl -26678
Antibody
Phospho-MAPKl/3 (pThr202/pTyr204) Cell Signaling Technology /9101
Antibody
Phospho-RAFl (pSer259) Antibody Thermo Fisher Scientific/44502
Phospho-RAFl (pSer259) Antibody Cell Signaling Technology /9421
Phospho-RPS6KA3 (pSer380) Antibody Thermo Fisher Scientific/44928G
Phospho-RPS6KA3 (pSer380) Antibody Cell Signaling Technology/11989
Phospho-MAPK8/9 pThrl83/pTyrl85 Antibody Cell Signaling Technology /9251
Phospho-MAPK8/9 pThrl83/pTyrl85 Antibody Thermo Fisher Scientific/MA5- 14943
Phospho-c-Raf (Ser338) Antibody Thermo Fisher Scientific/MA5-15176
Phospho-MEKl (Ser298) Antibody Cell Signaling Technology/98195
Phospho-MEKl/MEK2 (Ser217, Ser221) Thermo Fisher Scientific/MA5-15016
Antibody
Phospho-ATF2 (Thr71) Antibody Thermo Fisher Scientific/MA5-15088
Phospho-ATF-2 (Thr71) Antibody Cell Signaling Technology /9221
Phospho-SAPK/JNK (Thrl83/Tyrl85) Cell Signaling Technology /4668
Antibody
Table 2: List of IP to MS less successful antibodies for RAS-RAF-MAPK Pathway Proteins Antibody Name Company /Catalog Number
ALK Antibody Thermo Fisher Scientific/PA5- 14564
ARAF Antibody Thermo Fisher Scientific/PA5- 14924
ARAF Antibody Thermo Fisher Scientific/PA5-21354
BRAF Antibody Thermo Fisher Scientific/PA5- 19690
BRAF Antibody Thermo Fisher Scientific/PA5- 14933
BRAF Antibody Thermo Fisher Scientific/PA5- 14928
BRAF Antibody Thermo Fisher Scientific/MA5-15495
BRAF Antibody Thermo Fisher Scientific/MA5-15317
BRAF Antibody Millipore/07-453
CALM1 Antibody Thermo Fisher Scientific/PA5-11662
CALM1 Antibody Thermo Fisher Scientific/MA3-917
CALM1 Antibody Abcam/ab2860
CAMK2A Antibody Thermo Fisher Scientific/PA5-14315
CAMK2A Antibody Thermo Fisher Scientific/PA5- 14033
CAMK2A Antibody Thermo Fisher Scientific/A 16650
CAMK2A Antibody Thermo Fisher Scientific/A14012
CAMK2A Antibody Thermo Fisher Scientific/PA5-38239
CAMK2A Antibody Thermo Fisher Scientific/PA5-19128
CAMK2A Antibody Thermo Fisher Scientific/13-7300
CAMK2A Antibody Abcam/ab22609
CAMK2A Antibody Abcam/ab50202
CAMK2A Antibody Proteintech/20666-l-AP
CCND1 Antibody Thermo Fisher Scientific/PA5-24173
CCND1 Antibody Thermo Fisher Scientific/PA5-12255
Cyclin Dl Antibody Thermo Fisher Scientific/MAl-10324
Cyclin Dl / Bel- 1 Antibody Thermo Fisher Scientific/PA5-16777
Cyclin Dl / Bcl-1 Antibody Thermo Fisher Scientific/PA5-16607
Cyclin Dl / Bcl-1 Antibody Thermo Fisher Scientific/MA5- 12707
Cyclin Dl / Bcl-1 Antibody Thermo Fisher Scientific/710428
Cyclin Dl / Bcl-1 Antibody Thermo Fisher Scientific/701421
CDH1 Antibody Thermo Fisher Scientific/MAl-10192
CDH1 Antibody Thermo Fisher Scientific/MA5- 14408
CDH1 Antibody Thermo Fisher Scientific/MA5-11496
CDH1 Antibody Thermo Fisher Scientific/710161
CDH1 Antibody Thermo Fisher Scientific/701134
CDH1 Antibody Thermo Fisher Scientific/PA5-11548
CDH1 Antibody Thermo Fisher Scientific/PA5-11549
CDH1 Antibody Thermo Fisher Scientific/MA5-17013
CDH1 Antibody Thermo Fisher Scientific/MAl-06302
CDH1 Antibody Thermo Fisher Scientific/MAl-06304
CDH1 Antibody Thermo Fisher Scientific/MA 1-37202
CDH1 Antibody Thermo Fisher Scientific/PA5-32339
CDH1 Antibody Thermo Fisher Scientific/MAl-34228
CDH2 Antibody Thermo Fisher Scientific/PA5- 19486
CDH2 Antibody Thermo Fisher Scientific/PA5-29570 CDH2 Antibody Thermo Fisher Scientific/MAl-2002
CDH2 Antibody Thermo Fisher Scientific/33-3900
CDH2 Antibody Thermo Fisher Scientific/PA5-32283
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5-34805
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5-14456
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5- 12647
CDKNlA/p21 Antibody Thermo Fisher Scientific/PA5- 12646
CDKNlA/p21 Antibody Thermo Fisher Scientific/PAl-4185
CDKNlA/p21 Antibody Thermo Fisher Scientific/MAl-91045
CDKNlA/p21 Antibody Thermo Fisher Scientific/33-7000
CDKN1B Antibody Thermo Fisher Scientific/MAl -12302
CDKN1B Antibody Thermo Fisher Scientific/AHZ0452
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-16661
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-31212
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-30670
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-29914
CDKN2A/p 14ARF Antibody Thermo Fisher Scientific/PAl-28218
CDKN2A/pl6INK4a Antibody Thermo Fisher Scientific/MA5- 17093
CTNNAl Antibody Thermo Fisher Scientific/71-1200
CTNNBl Antibody Thermo Fisher Scientific/44207M
CTNNBl Antibody Thermo Fisher Scientific/MA5-15569
DDR2 Antibody Thermo Fisher Scientific/PA5- 14751
DDR2 Antibody Thermo Fisher Scientific/PA5 -27752
DDR2 Antibody Thermo Fisher Scientific/PA5-27730
DDR2 Antibody Thermo Fisher Scientific/PA 1-31993
DUSP1 Antibody Thermo Fisher Scientific/PA5- 15593
DUSP1 Antibody Thermo Fisher Scientific/PA5- 17973
DUSP22 Antibody Thermo Fisher Scientific/PA5 -29427
DUSP22 Antibody Thermo Fisher Scientific/PA5-33489
DUSP22 Antibody Thermo Fisher Scientific/PA5-33487
DUSP22 Antibody Proteintech/51005-2- AP
DUSP22 Antibody Abnova/H00056940-D01
DUSP4 Antibody Thermo Fisher Scientific/MA5-17225
DUSP4 Antibody Abcam/ab72593
DUSP4 Antibody Abcam/ab60229
DUSP6 Antibody Thermo Fisher Scientific/PA5-22162
DUSP6 Antibody Thermo Fisher Scientific/PA5-15552
DUSP6 Antibody Thermo Fisher Scientific/PAl-28321
DUSP6 Antibody Proteintech/10433-l-AP
EIF2A Antibody Thermo Fisher Scientific/PA5-41916
EIF2A Antibody Thermo Fisher Scientific/PA5-29593
EIF2A Antibody Thermo Fisher Scientific/PA5-27366
EIF2A Antibody Thermo Fisher Scientific/MAl-079
EIF2A Antibody Thermo Fisher Scientific/AH01182
EIF2A Antibody Thermo Fisher Scientific/AHO0802
EIF4E Antibody Thermo Fisher Scientific/PA5-24582 EIF4E Antibody Thermo Fisher Scientific/PA5-41751
EIF4EBP1 Antibody Thermo Fisher Scientific/PA5-30679
EIF4EBP1 Antibody Thermo Fisher Scientific/AH01382
EIF4EBP1 Antibody Thermo Fisher Scientific/MA5-15314
ERBB3 Antibody Thermo Fisher Scientific/MA5-13008
ERBB3 Antibody Thermo Fisher Scientific/MAl-860
ERBB3 Antibody Thermo Fisher Scientific/PA5-14636
ERBB3 Antibody Thermo Fisher Scientific/PAl-31989
ERBB3 Antibody Thermo Fisher Scientific/MAl-22819
ERBB4 Antibody Thermo Fisher Scientific/PA5 -29272
ERBB4 Antibody Thermo Fisher Scientific/PA5-14638
ERBB4 Antibody Thermo Fisher Scientific/PA5-14637
ERBB4 Antibody Thermo Fisher Scientific/PAl -20923
ERBB4 Antibody Thermo Fisher Scientific/PA5- 16789
ERBB4 Antibody Thermo Fisher Scientific/MA5-13789
ERBB4 Antibody Thermo Fisher Scientific/MA5-13016
ERBB4 Antibody Thermo Fisher Scientific/MAl-861
ERBB4 Antibody Thermo Fisher Scientific/PA5-32758
ERBB4 Antibody Millipore/05-478
ESR1 Antibody Thermo Fisher Scientific/PAl -308
ESR1 Antibody Thermo Fisher Scientific/MAl-12600
ESR1 Antibody Thermo Fisher Scientific/MA5- 12328
ESR1 Antibody Thermo Fisher Scientific/417000
ESR1 Antibody Thermo Fisher Scientific/MA5-15268
ESR1 Antibody Thermo Fisher Scientific/PA5-34577
ESR1 Antibody Thermo Fisher Scientific/PAl -37651
ESR1 Antibody Thermo Fisher Scientific/49-1002
ESR1 Antibody Thermo Fisher Scientific/MAl-310
FGFR1 Antibody Thermo Fisher Scientific/PA5-28564
FGFR1 Antibody Thermo Fisher Scientific/PA5 -25979
FGFR1 Antibody Thermo Fisher Scientific/PA5-24590
FGFR1 Antibody Thermo Fisher Scientific/PA5- 14649
FGFR1 Antibody Thermo Fisher Scientific/PA5- 14646
FGFR1 Antibody Thermo Fisher Scientific/PA5-18344
FGFR1 Antibody Thermo Fisher Scientific/PA5-27139
FGFR1 Antibody Thermo Fisher Scientific/PAl -24762
FGFR1 Antibody Thermo Fisher Scientific/MAl-90880
FGFR1 Antibody Thermo Fisher Scientific/MA 1-26256
FGFR1 Antibody Thermo Fisher Scientific/ 13 -3100
FGFR1 Antibody Thermo Fisher Scientific/PA5-32403
FGFR1 Antibody Thermo Fisher Scientific/PAl-37682
FGFR1 Antibody Millipore/05-1134
FGFR1 Antibody Millipore/05-149
FGFR2 Antibody Thermo Fisher Scientific/PA5- 14654
FGFR2 Antibody Thermo Fisher Scientific/PA5- 14653
FGFR2 Antibody Thermo Fisher Scientific/PA5- 14652 FGFR2 Antibody Thermo Fisher Scientific/PA5- 14651
FGFR2 Antibody Thermo Fisher Scientific/PA5-18914
FGFR2 Antibody Thermo Fisher Scientific/PA5 -29426
FGFR2 Antibody Thermo Fisher Scientific/PAl-31990
FGFR2 Antibody Thermo Fisher Scientific/P A 1-24764
FGFR2 Antibody Thermo Fisher Scientific/P A 1-24763
FGFR2 Antibody Thermo Fisher Scientific/P A5-32404
FGFR2 Antibody Thermo Fisher Scientific/PAl-37685
FGFR3 Antibody Thermo Fisher Scientific/P A5- 19782
FGFR3 Antibody Thermo Fisher Scientific/P A5-14655
FGFR3 Antibody Thermo Fisher Scientific/PA5-34574
FGFR3 Antibody Thermo Fisher Scientific/P A5-32405
FGFR3 Antibody Thermo Fisher Scientific/PAl-37687 c-fos Antibody Thermo Fisher Scientific/P A5- 13531 c-Fos Antibody Thermo Fisher Scientific/PA 1-24330 c-Fos Antibody Thermo Fisher Scientific/PA 1-830 c-Fos Antibody Thermo Fisher Scientific/OSCOOOl lG c-Fos Antibody Thermo Fisher Scientific/MA5- 17076 c-Fos Antibody Genetex/GTX27963
FOXOl Antibody Thermo Fisher Scientific/P A5-23132
FOXOl Antibody Thermo Fisher Scientific/MAl-23236
FOXOl Antibody Thermo Fisher Scientific/MAl-23234
FOXOl Antibody Thermo Fisher Scientific/MAl-23232
FOXOl Antibody Thermo Fisher Scientific/MA 1-23230
FOXOl Antibody Thermo Fisher Scientific/PAl-804
FOXOl Antibody Thermo Fisher Scientific/MA5- 17078
FOXOl Antibody Thermo Fisher Scientific/P A5-20972
FOXOl/3 Antibody Thermo Fisher Scientific/P A5-38276
FOXO 1/3/4 Antibody Thermo Fisher Scientific/P A5-36084
FOXO 1/3/4 Antibody Thermo Fisher Scientific/P A5-38274
FOX03 Antibody Thermo Fisher Scientific/PA5-27145
FOX03 Antibody Thermo Fisher Scientific/P A5-20973
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/PA5-14635
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/P A5- 14634
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/P A5- 14632
HER-2 / ErbB2 Antibody Thermo Fisher Scientific/MA5-16724
HER-2 / ErbB2 Antibody Antibody Thermo Fisher Scientific/P A5- 16774
HER-2 / ErbB2 Antibody Antibody Thermo Fisher Scientific/P A5 -20740
HER-2 / ErbB2 Antibody (40H87L57), Thermo Fisher Scientific/700635 ABfinity™ Rabbit Monoclonal Antibody
HER-2 / ErbB2 Antibody (7H3L20), Thermo Fisher Scientific/701399 ABfinity™ Rabbit Monoclonal Antibody
HER-2 / ErbB2 Antibody (7HCLC), ABfinity™ Thermo Fisher Scientific/710452 Rabbit Oligoclonal Antibody
HER-2 / ErbB2 Antibody (ICR55) Antibody Thermo Fisher Scientific/MAl-82367
HER-2 / ErbB2 Antibody (L87 + 2ERB19) Thermo Fisher Scientific/MA5-11976 Antibody HER-2 / ErbB2 Antibody (N12) Antibody Thermo Fisher Scientific/MA5- 12998
HER-2 / ErbB2 Antibody (N28) Antibody Thermo Fisher Scientific/MA5-13032
IQGAP1 Antibody Thermo Fisher Scientific/PA5-19189
IQGAP1 Antibody Thermo Fisher Scientific/PA5-34368
IQGAP1 Antibody Cell Signaling Technology /2293S
JAK1 Antibody Thermo Fisher Scientific/PA5-34811
JAK1 Antibody Thermo Fisher Scientific/PA5-27583
JAK2 Antibody Thermo Fisher Scientific/PA5-11267
JAK2 Antibody Thermo Fisher Scientific/PA5-34649
KSR1 Antibody Thermo Fisher Scientific/PA5-14937
KSR1 Antibody Thermo Fisher Scientific/PA5- 14027
KSR1 Antibody Thermo Fisher Scientific/MAl-25285
KSR1 Antibody Abcam/abl4516
MAP2K1 Antibody Thermo Fisher Scientific/PA5 -27693
MAP2K1 Antibody Thermo Fisher Scientific/MAl-095
MAP2K1 Antibody Thermo Fisher Scientific/PA5-15161
MAP2K1 Antibody Thermo Fisher Scientific/PA5- 17677
MAP2K1 Antibody Thermo Fisher Scientific/PA 1-21730
MAP2K1 Antibody Thermo Fisher Scientific/PA5-16556
MAP2K1 Antibody Thermo Fisher Scientific/ 13 -3500
MAP2K1 Antibody Thermo Fisher Scientific/710446
MAP2K2 Antibody Thermo Fisher Scientific/PA5 -29291
MAP2K2 Antibody Thermo Fisher Scientific/PA5 -27640
MAP2K2 Antibody Thermo Fisher Scientific/700829
MAP2K2 Antibody Thermo Fisher Scientific/PA5-15167
MAP2K2 Antibody Thermo Fisher Scientific/PA 1 -29852
MAP2K2 Antibody Thermo Fisher Scientific/PAl-41411
MAP2K2 Antibody Abcam/ab71828
MAP2K2 Antibody Cell Signaling Technology/9147S
MAPK1 Antibody Thermo Fisher Scientific/PA5- 14088
MAPK1 Antibody Thermo Fisher Scientific/PA5-14414
MAPK1 Antibody Thermo Fisher Scientific/PA 1-29167
MAPK1 Antibody Thermo Fisher Scientific/PA5-18329
MAPK1 Antibody Thermo Fisher Scientific/PA5-17710
MAPK1 Antibody Thermo Fisher Scientific/PAl-28196
MAPK1 Antibody Thermo Fisher Scientific/PA5-29636
MAPK1 Antibody Thermo Fisher Scientific/MAl-099
MAPK1 Antibody Thermo Fisher Scientific/LF-MA0193
MAPK1 Antibody Thermo Fisher Scientific/MA5- 15304
MAPK1/3 Antibody Thermo Fisher Scientific/MA5-15134
MAPK1/3 Antibody Thermo Fisher Scientific/82380
MAPK1/3 Antibody Thermo Fisher Scientific/61-7400
MAPK1/3 Antibody Thermo Fisher Scientific/44-654G
MAPK1/3 Antibody Thermo Fisher Scientific/13-6200
MAPK1/3 Antibody Thermo Fisher Scientific/710318
MAPK1/3 Antibody Thermo Fisher Scientific/710214 MAPK1/3 pan Antibody Thermo Fisher Scientific/PAl-25987
MAPK1/3 pan Antibody Thermo Fisher Scientific/MA5- 15227
MAPK11 Antibody Thermo Fisher Scientific/PA5-29302
MAPK11 Antibody Thermo Fisher Scientific/PA5- 14425
MAPK11 Antibody Thermo Fisher Scientific/PA5- 14424
MAPK11 Antibody Thermo Fisher Scientific/PA5-14050
MAPK11 Antibody Thermo Fisher Scientific/PAl -29850
MAPK11 Antibody Thermo Fisher Scientific/33-8700
MAPK11 Antibody Thermo Fisher Scientific/PAl -41154
MAPK3 Antibody Thermo Fisher Scientific/PAl -30387
MAPK3 Antibody Thermo Fisher Scientific/MAl-13041
MAPK3 Antibody Thermo Fisher Scientific/13-8600
MAPK3 Antibody Thermo Fisher Scientific/701183
MAPK3 Antibody Thermo Fisher Scientific/PA5-14413
MAPK3 Antibody Thermo Fisher Scientific/PAl-21015
MAPK3 Antibody Thermo Fisher Scientific/PA5-32911
MAPK3 Antibody Thermo Fisher Scientific/PA5-32912
MAPK3 Antibody Thermo Fisher Scientific/PA5-32913
MAPK3 Antibody Thermo Fisher Scientific/PAl -41413
MAPK3 Antibody Thermo Fisher Scientific/PAl -9041
MAPK3 Antibody Thermo Fisher Scientific/PAl -37638
MAPK3 Antibody Thermo Fisher Scientific/PA5-32395
MAPK8 Antibody Thermo Fisher Scientific/PA5-21343
MAPK8 Antibody Thermo Fisher Scientific/PA5-25151
MAPK8 Antibody Thermo Fisher Scientific/PA5-14418
MAPK8 Antibody Thermo Fisher Scientific/PA5- 17889
MAPK8 Antibody Thermo Fisher Scientific/44-690G
MAPK8 Antibody Thermo Fisher Scientific/710075
MAPK8 Antibody Thermo Fisher Scientific/MA5-17117
MAPK9 Antibody Thermo Fisher Scientific/PA5-28262
MAPK9 Antibody Thermo Fisher Scientific/MA5-15183
MAPK9 Antibody Thermo Fisher Scientific/AH01162
MAPK9 Antibody Thermo Fisher Scientific/PAl -41234
MET Antibody Thermo Fisher Scientific/MA5-15198
MET Antibody Thermo Fisher Scientific/MA5-23760
NF1 Antibody Thermo Fisher Scientific/MAl-085
NF1 Antibody Thermo Fisher Scientific/MAl-084
NF1 Antibody LifeSpan BioSciences/LS-C2721
NOTCH 1 Antibody Thermo Fisher Scientific/MAl-91405
NOTCH 1 Antibody Thermo Fisher Scientific/MA5-11961
NOTCH 1 Antibody Thermo Fisher Scientific/PA5-23181
NOTCH 1 Antibody Thermo Fisher Scientific/MAl-81888
PAK1 Antibody Thermo Fisher Scientific/PA5-29256
PAK1 Antibody Thermo Fisher Scientific/PA5 -29224
PAK1 Antibody Thermo Fisher Scientific/PA5-34696
PAK1 Antibody Thermo Fisher Scientific/PA5-15115 PAK1 Antibody Thermo Fisher Scientific/PA5-18557
PAK1 Antibody Thermo Fisher Scientific/PAl-28385
PAK1,2 Antibody Thermo Fisher Scientific/PA5-36918
PAK1,2 Antibody Thermo Fisher Scientific/PA5-38693
PAK1,2,3 Antibody Thermo Fisher Scientific/PA5-36102
PAK1,2,3 Antibody Thermo Fisher Scientific/PA5-38311
PAK1,2,3 Antibody Thermo Fisher Scientific/PA5-38310 pan MAP2K Antibody Thermo Fisher Scientific/PAl- 10034 pan MAP2K Antibody Thermo Fisher Scientific/PA5-31917 pan MAP2K Antibody Thermo Fisher Scientific/MA5-15162 pan MAP2K Antibody Thermo Fisher Scientific/MA5-15135 pan MAP2K Antibody Thermo Fisher Scientific/PA5-31918 pan MAPK8/9 Antibody BD Biosciences/554285
Pan-Cadherin Antibody Thermo Fisher Scientific/PA5- 19479
PARP1 Antibody Thermo Fisher Scientific/PA5-34803
PARP1 Antibody Thermo Fisher Scientific/PA5-34802
PARP1 Antibody Thermo Fisher Scientific/PA5-13386
PARP1 Antibody Thermo Fisher Scientific/PA5-27219
PARP1 Antibody Thermo Fisher Scientific/PA5- 16452
PARP1 Antibody Thermo Fisher Scientific/A21969
PARP1 Antibody Thermo Fisher Scientific/436400
PARP1 Antibody Thermo Fisher Scientific/MAl-41020
PARP1 Antibody Thermo Fisher Scientific/PA5-32561
PARP1 Antibody Thermo Fisher Scientific/PAl -38414
PGR Antibody Thermo Fisher Scientific/MA5- 12653
PGR Antibody Thermo Fisher Scientific/MAl-412
PGR Antibody Thermo Fisher Scientific/PA5-16435
PGR Antibody Thermo Fisher Scientific/PA5-31314
PGR Antibody Thermo Fisher Scientific/MAl-23267
PGR Antibody Thermo Fisher Scientific/MAl-23268
PGR Antibody Thermo Fisher Scientific/PA5-34849
PGR Antibody Thermo Fisher Scientific/PA5- 17226
PI3KCA Antibody Thermo Fisher Scientific/PA5- 15246
PI3KCA Antibody Thermo Fisher Scientific/PA5-18610
PI3KCA Antibody Thermo Fisher Scientific/PA5-27192
PI3KCA Antibody Thermo Fisher Scientific/MA5-17149
PIK3R1 Antibody Thermo Fisher Scientific/710400
PI3KR2 Antibody Thermo Fisher Scientific/PA5- 15262
PSMG1 Antibody Thermo Fisher Scientific/PA5-31298
PSMG1 Antibody Abgent/AI 12626
PSMG1 Antibody Acris/TA338919
PSMG1 Antibody Acris/TA338920
RAF1 Antibody Thermo Fisher Scientific/PA5-29333
RAF1 Antibody Thermo Fisher Scientific/PA5- 14941
RAF1 Antibody Thermo Fisher Scientific/MAl-90087
RAF1 Antibody Thermo Fisher Scientific/MA 1-21482 RAF1 Antibody Thermo Fisher Scientific/PA5 -20970
RAF1 Antibody Cell Signaling Technology /53745S
Ras- H Antibody Thermo Fisher Scientific/PA5- 14863
Ras- H Antibody Thermo Fisher Scientific/MAl-19726
Ras- H Antibody Thermo Fisher Scientific/PA5-22392
Ras- K Antibody Thermo Fisher Scientific/MAl-91046
Ras- K Antibody Thermo Fisher Scientific/415700
RASGRF1 Antibody Thermo Fisher Scientific/PA5- 14531
RASGRF1 Antibody Abcam/ab 190081
RASGRF2 Antibody Thermo Fisher Scientific/PA5 -28867
RASGRF2 Antibody Thermo Fisher Scientific/PA5-28857
RASGRF2 Antibody Abcam/ab 176008
Ras-N Antibody Thermo Fisher Scientific/PA5- 14833
RICTOR Antibody Thermo Fisher Scientific/PA5-14104
RPS6KB2 Antibody Thermo Fisher Scientific/PA5-26010
RPS6KB2 Antibody Thermo Fisher Scientific/PA5-15235
Raptor Antibody Thermo Fisher Scientific/PA5-20126
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/LF-MA0183
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-15135
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/AH01472
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/MA5-15341
RSK1 (RPS6KA1) Antibody Thermo Fisher Scientific/PA5-20134
RSK1 + RSK2 + RSK3 Antibody Thermo Fisher Scientific/PA5-17680
RSK1 + RSK2 + RSK3 Antibody Thermo Fisher Scientific/MA5-15040
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/PA5 -29280
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/PA5-15140
RSK2 (RPS6KA3) Antibody Thermo Fisher Scientific/MA5-15920
RSK3 (RPS6KA2) Antibody Thermo Fisher Scientific/PA5 -29222
SMAD4 Antibody Thermo Fisher Scientific/PA5-35330
SMAD4 Antibody Thermo Fisher Scientific/710714
SOS1 Antibody Thermo Fisher Scientific/MA5- 17234
SPRED1 Antibody Millipore/MABN478
SPRED2 Antibody Thermo Fisher Scientific/PA5-31038
SPRED2 Antibody Thermo Fisher Scientific/PA5 -20625
SPRED2 Antibody Abcam/ab50535
SPRED2 Antibody Abcam/ab58127
SPRY1 Antibody Thermo Fisher Scientific/PA5-43582
SPRY1 Antibody Abcam/ab75492
SPRY2 Antibody Thermo Fisher Scientific/PA5-43584
SPRY2 Antibody Thermo Fisher Scientific/PA5-43583
SPRY3 Antibody Abcam/abl80037
SPRY3 Antibody Novus Bio/AF5735
SPRY3 Antibody ProSci/30-623
SPRY4 Antibody Thermo Fisher Scientific/PA5-31401
SPRY4 Antibody Thermo Fisher Scientific/40-9300
STAT1 Antibody Thermo Fisher Scientific/MAl-037 STAT3 Antibody Thermo Fisher Scientific/710077
STAT3 Antibody Thermo Fisher Scientific/PAl -86605
STK11 Antibody Thermo Fisher Scientific/PA5- 14074
STK11 Antibody Thermo Fisher Scientific/PA5- 14072
STK11 Antibody Thermo Fisher Scientific/MA5- 14831
STK11 Antibody Thermo Fisher Scientific/PAl-12767
STK11 Antibody Thermo Fisher Scientific/PA5-20325
TP53 Antibody Thermo Fisher Scientific/PA5 -27822
TP53 Antibody Thermo Fisher Scientific/MAl-7629
TP53 Antibody Thermo Fisher Scientific/701270
TP53 Antibody Thermo Fisher Scientific/710294
Phospho-p38 MAPK (Thrl80/Tyrl82) Antibody Cell Signaling Technology /4511
Phospho-p38 MAPK (Thrl80/Tyrl82) Antibody Cell Signaling Technology /9211
Phospho-p38 MAPK (Thrl80/Tyrl82) Antibody Cell Signaling Technology /4631
Phospho-p38 MAPK (Thrl80/Tyrl82) Antibody Cell Signaling Technology/9215
Phospho-p38 MAPK (Thrl80/Tyrl82) Antibody Cell Signaling Technology/9216
Phospho-MEK3/MEK6 (Serl89, Ser207) Thermo Fisher Scientific/PA5- 17887
Antibody
Phospho-MKK3 (Serl89)/MKK6 (Ser207) Cell Signaling Technology/12280
Antibody
Phospho-MKK3 (Serl89)/MKK6 (Ser207) Cell Signaling Technology /9236
Antibody
Phospho-MSKl (Thr581) Antibody Cell Signaling Technology /9595
Phospho-MAPKAPK2 (Thr334) Antibody Cell Signaling Technology /3007
Phospho-MAPKAPK2 (Thr334) Antibody Thermo Fisher Scientific/PA5- 17791
Phospho-SEKl/MKK4 (Ser257) Antibody Cell Signaling Technology /4514
Phospho-SEKl/MKK4 (Ser257/Thr261) Cell Signaling Technology 19156
Antibody
[0069] The immunoprecipitated RAS -RAF -MAPK pathway proteins may be reduced and alkylated prior to fragmentation (e.g., digestion). Samples that have been reduced and alkylated may comprises modifications, such as to cysteine residues (e.g., CAM). Where a RAS -RAF -MAPK peptide of SEQ ID NO: 1 - 1400 shows modification resulting from, for example, reduction/alkylation, the non-modified peptide is also encompassed. For example, in each instance where a RAS-RAF-MAPK pathway peptide of SEQ ID NO: 1 - 1400 is referred to, also encompassed are unmodified peptides of SEQ ID NO: 1 - 1400.
[0070] The samples may optionally be desalted prior to analysis by mass spectrometry.
Both enzymatic and chemical digestion is encompassed. Enzymatic digestion includes, but is not limited to, digestion with a protease such as, for example, trypsin, chymotrypsin, AspN, GluC, LysC, LysN, ArgC, proteinase K, pepsin, Clostripain, Elastase, GluC biocarb, LysC/P, LysN Promise, Protein Endopeptidase, Staph Protease or thermolysin. Chemical digestion includes use of, for example, CNBr, iodosobenzoate and formic acid. [0071] In some embodiments, after fragmentation (e.g., digestion), peptide samples are analyzed by mass spectrometry (MS), and the resulting spectra are compared with theoretical spectra from known proteins to determine the peptides and proteins in a sample. For RAS- RAF-MAPK pathway proteins, discovery MS is cumbersome and time consuming and is not a viable clinical method. Therefore, the inventors have identified novel peptides that associate with RAS-RAF-MAPK pathway proteins for use in the IP-MS methods. Use of these peptides in targeted MS, and IP -targeted MS methods allows quantitation of even low abundant RAS- RAF-MAPK proteins. Moreover, use of these peptides in targeted MS, and in IP-targeted MS methods, allows quantitation of phosphorylated RAS-RAF-MAPK proteins.
[0072] Theoretically, peptides useful in MS to detect and quantify RAS-RAF-MAPK pathway proteins can be designed by use of computer software and the like. Surprisingly, however, many of these potential peptide sequences are unsuitable or ineffective for use in MS-based assays, including SRM/MRM and PRM. Because it was not possible to predict the most suitable peptides for MS analysis, it was necessary to experimentally identify modified and unmodified peptides to develop as clinical reagents. To complicate the analysis, it was discovered that certain peptides useful when assaying typical samples were not predictive when assaying samples that had undergone immunoprecipitation.
[0073] Typically, targeted MS is performed by quantifying specific unique peptides of the protein. In some embodiments, known amounts of isotope-labeled (e.g., heavy isotope- labeled) versions of these targeted peptides can be used as internal standards for absolute quantitation. In some instances, proteins of interest are not detectable even after identifying unique peptide standards. The combination of specific antibodies with specific target peptides has allowed the inventors to improve the sensitivity of detection of RAS-RAF-MAPK pathway proteins by MS, and has allowed for lower levels of detection and lower levels of
quantification than ever previously seen. See, e.g., Figure 3.
[0074] In some embodiments, the RAS-RAF-MAPK pathway peptides provided in the kits, and useful in the described methods, are listed in Table 3. SEQ ID Nos: 1-700 are native peptide sequences useful in identifying the RAS-RAF-MAPK pathway proteins recited in the "Target ID" column. Certain peptide sequences are phosphorylated at certain residues as shown in parentheses "(P03H2)" following the modified residue.
[0075] Certain peptides are modified at cysteine residues as shown by "(CAM)" following the modified residue. The "CAM" post-translational modification is well known to those of skill in the art to mean carbamidomethylation, resulting from alkylation of the protein/peptide. The peptides may be as shown in Table 3, or may be non-modified version of these peptides lacking carbamidomethylation. Table 3. List of peptides to quantitate RAS-RAF-MAPK Pathway proteins
[0076] In some embodiments, the peptides reagents, and the peptides useful in the methods, are recited in Table 5 (SEQ ID Nos: 13, 15, 18, 28, 31, 47, 48, 51, 127, 128, 132, 133, 141, 142, 143, 144, 171, 173, 177, 180, 181, 182, 183, 190, 192, 213, 219, 220, 224, 226, 231, 233, 234, 235, 236, 258, 270, 295, 297, 300, 301, 302, 304, 306, 308, 310, 347, 348, 353, 362, 392, 393, 405, 416, 429, 443, 446, 451, 467, 483, 487, 501, 502, 506, 507, 510, 512, 521, 522, 523, 528, 572, 580, 588, 591, 598, 603, 615, 617, 635, 636, 655, 657, 660, 662, 670, 678, 683, 691, 692, 696, 698, and 699). In some embodiments, the peptides of Table 5 are useful in multi-plex MS methods.
[0077] In some embodiments, protein samples are denatured or solubilized before fragmentation.
[0078] In some embodiments, the fragmentation protocol uses chemical cleavage. In some embodiments, the chemical cleavage uses CNBr. In some embodiments, the
fragmentation protocol is done using an enzyme. In some embodiments, the fragmentation protocol uses MS-grade commercially available proteases. Examples of proteases that may be used to digest samples include trypsin, endoproteinase GluC, endoproteinase ArgC, pepsin, chymotrypsin, LysN protease, LysC protease, GluC protease, AspN protease, proteinase K, and thermolysin. In some embodiments, a mixture of different proteases are used and the individual results are combined together after the digestion and analysis. In some
embodiments, the digestion is incomplete in order to see larger, overlapping peptides. In some embodiments, the antibody digestion is performed with IdeS, IdeZ, pepsin, or papain to generate large antibody domains for "middle-down" protein characterization. In some embodiments, the fragmentation protocol uses trypsin that is modified. In some embodiments, a protein: protease ratio (w/w) of 10: 1, 20: 1, 25: 1, 50: 1, 66: 1, or 100: 1 may be used. In some embodiments, the trypsin used is at a concentration of about 100 ng/ml-1 mg/ml, or about 100 ng/ml-500μg/ml, or about 100 ng/ml-100μg/ml, or about 1 μg/ml-lmg/ml, or about 1 μg/ml-500μg/ml, or about 1 μg/ml-100μg/ml, or about 10 μg/mg-lmg/ml, or about 10 μg/mg- 500 μg/ml, or about 10 μg/mg-100μg/ml. In some embodiments, the digestion step is for about 10 minutes to 48 hours, or about 30 minutes to 48 hours, or about 30 minutes to 24 hours, or about 30 minutes to 16 hours, or about 1 hour to 48 hours, or about 1 hour to 24 hours, or about 1 hour to 16 hours, or about 1 to 8 hours, or about 1 to 6 hours, or about 1 to 4 hours. In some embodiments, the digestion step is incubated at a temperature from about 20°C to 45°C, or from about 20°C to 40°C, or from about 22°C to 40°C, or from about 25°C to 37°C. In some embodiments, the digestion step is incubated at about 37°C or 30°C. In some embodiments, a step is included to end the digestion step. The step to end the digestion protocol may be addition of a stop solution or a step of spinning or pelleting of a sample. In some embodiments, the digestion is followed by guanidination.
[0079] In some embodiments, the fragmentation protocol includes use of protein gels.
In some embodiments, the fragmentation protocol comprises in-gel digestion. An exemplary commercially available kit for performing in-gel digestion is the In-Gel Tryptic Digestion Kit (Thermo Fisher Cat#89871).
[0080] In some embodiments, the fragmentation protocol is carried out in solution. An exemplary commercially available kit for performing in-solution digestion is the In-Solution Tryptic Digestion and Guanidination Kit (Thermo Fisher Cat#89895).
[0081] In some embodiments, the fragmentation protocol uses beads. In some embodiments, the fragmentation protocol comprises on-bead digestion. In some embodiments, agarose beads or Protein G beads are used. In some embodiments, magnetic beads are used.
[0082] In some embodiments, protein samples are separated using liquid
chromatography before MS analysis. In some embodiments, fragmented samples are separated using liquid chromatography before MS analysis.
[0083] The IP and IP-MS methods described herein are capable of detecting phosphorylated RAS-RAF-MAPK pathway proteins, including those described in Table 4.
Table 4. List of Total RAS-RAF-MAPK Pathway Target Proteins 3 BRAF P15056 42 MAPK3 P27361
4 CALM1 P62158 43 MAPK8 P45983
5 CAMK2A Q9UQM7 44 MAPK9 P45984
6 CCND1 P24385 45 MET P08581
7 CDH1 P12830 46 NF1 P21359
8 CDH2 P 19022 47 NOTCH 1 P46531
9 CDK2 P24941 48 NRAS P01111
10 CDKN1A P38936 49 PAK1 013153
11 CDKN1B P46527 50 PARP1 P09874
12 CDKN2A Q8N726 51 PGR P06401
13 CTNNA1 P35221 52 PIK3CA P42336
14 CTNNB1 P35222 53 PIK3R1 P27986
15 DDR2 Q16832 54 PIK3R2 000459
16 DUSP22 Q9NRW4 55 PSMG1 095456
17 DUSP4 Q13115 56 RAF1 P04049
18 DUSP6 Q 16828 57 RASA1 P20936
19 EGFR P00533 58 RASGRF1 Q13972
20 EIF2A Q9BY44 59 RASGRF2 014827
21 EIF4E P06730 60 RICTOR Q6R327
22 EIF4EBP1 Q13541 61 RPS6KA1 Q15418
23 ERBB2 P04626 62 RPS6KA2 Q15349
24 ERBB3 P21860 63 RPS6KA3 P51812
25 ERBB4 Q15303 64 RPS6KB2 Q9UBS0
26 ESR1 P03372 65 RPTOR Q8N122
27 FBX07 Q9Y3I1 66 SMAD3 P84022
28 FGFR1 P11362 67 SMAD4 Q13485
29 FGFR3 P22607 68 SOS1 Q07889
30 FOS P01100 69 SPRED1 Q7Z699
31 FOXOl 012778 70 SPRED2 Q7Z698
32 FOX03 043524 71 SPRY1 043609
33 HRAS P01112 72 SPRY2 043597
34 IQGAP1 P46940 73 SPRY3 043610
35 JAK1 P23458 74 SPRY4 Q9C004
36 JAK2 060674 75 STAT1 P42224
37 KRAS P01116 76 STAT3 P40763
38 MAP2K1 Q02750 77 STK11 Q15831
39 MAP2K2 P36507 78 TP53 P04637
79 ATF2 P15336 80 MAPK12 P53778
81 MAPK13 015264 82 MAPK14 Q16539
83 MAP2K3 P46734 84 MAP2K6 P52564
85 RPS6KA5 075582 86 MAPKAPK2 P49137
[0084] In some embodiments, the RAS-RAF-MAPK pathway peptides used in the MS methods described herein have limits of detection considered useful in clinical and research methods. See, e.g, Table 5. In some embodiments, the RAS-RAF-MAPK pathway peptides used in the MS and IP-MS methods comprise or consist of the peptides described in Table 5. In some embodiments, the peptides of Table 5 are detectably labelled.
Table 5. Lower Limit of uantitation of Pe tides for RAS-RAF-MAPK Pathwa Proteins
SPRY1 4 FirC(CAM)lEQrC(CAM)lGK 657 0.14
SPRY2 2 LHGLPEHR 660 3.70
SPRY2 4 EDLGLHAYR 662 0.05
SPRY4 2 TSHVENDYIDNPSLALTTGPK 670 3.70
STAT3 1 FLQESNVLYQHNLR 678 3.70
STAT3 6 FNILGTNTK 683 0.05
TP53 1 TYQGSYGFR 691 0.05
TP53 2 LGFLHSGTAK 692 1.23
TP53 6 VEYLDDR 696 0.14
TP53 8 ALPNNTSSSPQPK 698 0.14
TP53 9 ELNEALELK 699 0.14
Table 6. List of antibodies for multi- lex IP sin le- lex IP +/- MS .
FBX07 Millipore ABN1038
FBX07 Novus Bio NBP1-55051
FOS Thermo Fisher Scientific MA5-15055
FOS Thermo Fisher Scientific PA5- 17489
FOXOl Thermo Fisher Scientific MA5- 14846
FOX03 Cell Signaling Technology 12829
HRAS Thermo Fisher Scientific 33-7200
KRAS/HRAS/NRAS Thermo Fisher Scientific MA1-012
IQGAP1 Thermo Fisher Scientific 33-8900
JAK1 Cell Signaling Technology 3332
JAK1 Cell Signaling Technology 3344
JAK2 Cell Signaling Technology 3230
MAP2K1 Thermo Fisher Scientific MA5-15093
MAP2K2 Abeam ab28834
MAPK1 Thermo Fisher Scientific PA1-21016
MAPK1/MAPK3 Proteintech 66192-1-Ig
MAPK11 Abeam ab80116 pan MAPK8/9 Proteintech 51153-1-AP
MAPK9 Thermo Fisher Scientific PA5-28664
MET Thermo Fisher Scientific PA1-28026
MET Thermo Fisher Scientific PA5-17148
MTOR Thermo Fisher Scientific PA1-188
MTOR Thermo Fisher Scientific PA1-518
NF1 Millipore 07-730
NF1 Abeam ab 17963
NOTCH 1 Cell Signaling Technology 3608
PAK1 Thermo Fisher Scientific 71-9300
Pan-Cadherin Thermo Fisher Scientific 71-7100
Pan-Cadherin Thermo Fisher Scientific PA1-37199
PARP1 Thermo Fisher Scientific MA5-15031
PIK3CA Millipore 09-481
PIK3R2 Thermo Fisher Scientific MA1-90048
PSMG1 Cell Signaling Technology 13378
RAF1 Millipore 07-396
RAF1 Thermo Fisher Scientific PA5-28652
RASA1 Abeam ab2922
RASA1 Thermo Fisher Scientific MA4-001
RICTOR Cell Signaling Technology 9476
RICTOR Abeam ab70373
RSK1 (RPS6KA1) Cell Signaling Technology 8408
RSK1 (RPS6KA1) Thermo Fisher Scientific PA5-21699
RSK2 (RPS6KA3) Thermo Fisher Scientific 38-6800
[0085] In one instance, total TP53 and phosphorylated TP53 are evaluated together. In some embodiments, KRAS, HRAS, and NRAS are evaluated together. In other embodiments, EGFR, SOSl, ARAF, BRAF, RAFl, KRAS, HRAS, and NRAS, RPS6KA1, PIK3R1, PIK3R2 and PIK3CA are evaluated together. In some embodiments, ERBB2, SOSl, ARAF, BRAF, RAFl, KRAS, HRAS, and NRAS, RPS6KA1, PIK3R1, PIK3R2 and PIK3CA are evaluated together. In some embodiments, SPRY1, SPRY2, DUSP4, RASA1, NF1, SPRED1, SPRED2, KRAS, HRAS, and NRAS are evaluated together. In some embodiments, MAPKl/3 and TP53 are evaluated together (including either total protein or phosphorylated forms, such as, for example MAPKl/3 (including phosphorylated form pThr202/pTyr204) and TP53 (including phosphorylated form pSerl5)). In some embodiments, PIK3R1, PIK3R2, PIK3CA, ARAF, BRAF, RAFl, KRAS, HRAS, NRAS, RPS6KA1, RPS6KB1, AKT1, AKT2, AKT3, MTOR, phosphor-TP53 (pSerl5), phosphor-MAPKl/3 (pThr202/pTyr204) and phospho-MAPK8/9 (pThrl83/pTyrl85) are evaluated together. Any of the antibodies referenced in Table 6 corresponding to these proteins may be employed in a multi-plex IP format, for example, as in the groups set forth in Table 7.
Table 7. Selected combinations of antibodies for multi-plex IP (+/- MS) (when more than one
EXAMPLES
[0086] The following examples are provided to illustrate certain disclosed
embodiments and are not to be construed as limiting the scope of this disclosure in any way.
Example 1 - Immunoprecipitation of RAS-RAF-MAPK pathway proteins and Discovery- MS
[0087] RAS-RAF-MAPK pathway proteins play central roles in diseases including cancer. The identification of RAS-RAF-MAPK pathway proteins, while desired as a means for monitoring disease progression, and as a tool for scientific research, has been limited in part because of the low abundance of RAS-RAF-MAPK pathway proteins, and in part due to a lack of validated methods and reagents. Phosphorylated RAS-RAF-MAPK pathway proteins are particularly important to identify and quantify as a measure of protein activation status, and also as markers for disease progression. As shown in Figure 1, methods and reagents for detecting RAS-RAF-MAPK pathway proteins, including phosphorylated proteins, and their protein interactions, were designed and tested. Multiplex immunoprecipitation (IP) to MS (mlP-MS) was assessed for the ability to measure total and phosphorylated RAS-RAF-MAPK pathway targets. mlP-MS methods were also compared to existing singleplex immunoassay (Western Blot (WB) and ELISA) and multiplex Luminex assays.
[0088] Immunoprecipitation and MS Sample Preparation
[0089] The Thermo Scientific™ Pierce MS-Compatible Magnetic IP Kit (Protein A/G) was used to screen and validate antibodies for 78 RAS-RAF-MAPK pathway proteins from 500μg of cell lysate. Validated antibodies were biotinylated with the Thermo Scientific™ Pierce Antibody Biotinylation Kit for IP. The Thermo Scientific™ Pierce MS-Compatible Magnetic IP Kit (Streptavidin) was used to perform the single or multiplex IPs for target enrichment. IP samples were processed by an in-solution digestion method where IP eluates were reconstituted in 6M Urea, 50mM triethylammonium bicarbonate (TEAB), pH 8.5 followed by reduction, alkylation and trypsin digestion overnight at 37°C. The digested samples were acidified with trifluoroacetic acid (TFA) before MS analysis.
[0090] Immunoprecipitation with Enzyme Elution and MS Sample Preparation
[0091] An additional method employing a shorter trypsin digestion was developed
(data not shown). Antibodies and appropriate lysate were incubated overnight at 4°C with rotation. The next day, immune complexes were washed and allowed to incubate with l ^g trypsin in 50mM TEAB for 1 hour and 37°C with 800rpm shaking in a thermomixer. Enzyme derived IP elutions were separated from the beads and the beads were allowed to incubate with an MS compatible elution buffer (Thermo Fisher Scientific, PN: 90409) for 10 minutes at room temperature. This second elution was collected separately. The second elution was dried down in a speedvac and processed with a urea based in-solution digestion method in which IP eluates were reconstituted in 6M Urea, 50mM TEAB, pH 8.5 followed by reduction, alkylation and trypsin digestion overnight at 37°C. The digested samples were acidified with TFA before MS analysis.
[0092] The enzyme-derived IP elution was combined with 25ng Green Fluorescent
Protein (GFP) and exposed to a solution of Tris[2-
Carboxyethyl]phosphine (TCEP)/Chloroacetamide at a 1 :4 ratio for 5-10 minutes at 95°C and then allowed to cool briefly before addition of 600ng trypsin and incubation for 2 hours at 37°C with 500rpm in a thermomixer. The trypsin-digested samples were neutralized with 10% TFA and dried down in a speedvac. Samples were reconstituted in 5% acetonitrile (ACN) and 0.1% TFA and taken to LC-MS analysis.
[0093] Liquid Chromatography and Mass Spectrometry
[0094] Prior to MS analysis, tryptic digest samples were desalted on-line using the
Thermo Scientific™ Acclaim™ PepMap 100 C18 Trap Column. For discovery MS, the samples were analyzed by nanoLC-MS/MS using a Thermo Scientific™ Dionex™ UltiMate™ 3000 RSLCnano System and Thermo Scientific™ Q Exactive™ HF Hybrid Quadrupole- Orbitrap Mass Spectrometer. For targeted MS, the samples were analyzed using the UltiMate 3000 RSLCnano System and the Thermo Scientific™ TSQ™ Vantage™ Mass Spectrometer (SRM mode) or the Thermo Scientific™ Q Exactive™ HF Hybrid Quadrupole-Orbitrap Mass Spectrometer (PRM mode).
[0095] MS Data Analysis
[0096] Discovery MS data were analyzed with Thermo Scientific™ Proteome
Discoverer™ 1.4 to assess percent sequence coverage, unique peptides, MSI intensities, spectral counts and PTMs. The Proteome Discoverer software searches were executed using the Uniprot human protein database. Tryptic peptides with highest MS 1 intensity and relevant phosphorylation sites were selected from the discovery data for targeted assay development. For targeted MS data analysis, Thermo Scientific™ Pinpoint software and Skyline software (University of Washington) were used to measure limit of quantitation (LOQ) from the calibration curve and target analyte concentration from unknown samples.
[0097] Results
[0098] As shown in Figure 2, RAS-RAF-MAPK pathway proteins were
immunoprecipitated from HCT116 or BT549 cell lysates with Thermo Scientific™ Pierce MS- Compatible Magnetic IP Kits (Protein A/G or Streptavidin) for MS analysis. A variety of antibodies were screened to determine effectiveness in both ability to IP RAS-RAF-MAPK pathway proteins, and also for their usefulness when combined with MS. Table 1 (above) provides a list of antibodies validated for use in the IP-MS methods. Table 2 (above) provides a list of antibodies tested, but found to be less successful.
[0099] Higher numbers of unique peptides were identified in IP enriched samples as compared to neat (non-IP-enriched) lysate. See Figure 2. Protein isoforms and interacting protein partners were identified for RAS (K, H, N), JNKs (MAPK8, MAPK9), PI3K (PIK3CA, PIK3CB, PIK3R1, PIK3R2), and SOS l targets. Relevant phosphor peptides were identified for ERbb2, PIK3R2, RAF1, RPS6KA1, SOSl and TP53 targets. Candidate quantitative peptides were selected for targeted MS assay development.
[00100] Limits of detection (LOD) and lower limits of quantification (LLOQ) were analyzed for RAS-RAF-MAPK pathway proteins, including BRAF, ERBB2, FOS, FOXOl, FOX03, HRAS, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPK8, MAPK9, NRAS, RPS6KA1, SOSl, and TP53. Results are presented in Figure 3. The assay dynamic range, representing the concentration range between the lower to upper limits of quantification (LLOQ to ULOQ), is the range where protein concentration is measurable with acceptable levels of accuracy and precision. To ensure linearity of the measurement, for each internal standard peptide the linear signal-to-abundance range (LLOQ and ULOQ) was determined from dilution series experiments spanning concentrations of 300-0.05 fmol on column, spiked into a constant light peptide at 36fmol and 200ng of equimolar concentration of 6 proteins digest. In some instances, lower limits of detection and quantification may be established, even though these lower limits were not presently tested. Thus, the lower limits are no more than the numbers determined experimentally.
Example 2 - Multiplex IP of RAS-RAF-MAPK pathway proteins and multiplex MS
[00101] Multiple RAS-RAF-MAPK pathway protein targets were enriched
simultaneously from unstimulated and human insulin-like growth factor (hlGF-l)-stimulated HCT116 lysate with biotinylated antibodies and Thermo Scientific™ Pierce MS-Compatible Magnetic IP Kit (Streptavidin). HCT116 cells were starved in 0.1% charcoal stripped fetal bovine serum (FBS) for 24 hours before stimulation with lOOng/ml of IGF for 15 minutes. Validated IP-MS antibodies are biotinylated for 29 RAS-RAF-MAPK pathway targets using the Thermo Scientific™ Pierce Antibody Biotinylation Kit for IP (PN: 90407) as
recommended in instruction manual. 29 total targets were grouped into three different panels for multi-plex IP. ^g of each biotinylated antibody for each panel comprising 10-15 total targets were added simultaneously to 1000μg of control and IGF stimulated HCT116 cell lysate in duplicate. IP was performed as recommended in the Thermo Scientific™ Pierce MS- Compatible Magnetic IP Kit (Streptavidin) (PN: 90408) with the following modification. 5 micrograms of streptavidin magnetic beads per microgram of biotinylated antibody concentration was used for multi-plex IP.
[00102] IP samples were processed by an in-solution digestion method where IP eluates were reconstituted in 6M Urea, 50mM TEAB, pH 8.5 followed by reduction (5mM TCEP for 30 minutes at 35°C), alkylation (20mM Iodoacetamide in dark at room temperature for 30 minutes) and trypsin digestion overnight at 37°C. The digested samples were acidified with 3.5μ1. of 10% TFA before discovery MS analysis. For discovery MS, the samples were analyzed by nanoLC-MS/MS using a Thermo Scientific™ Dionex™ UltiMate™ 3000 RSLCnano System and Thermo Scientific™ Q Exactive™ HF Hybrid Quadrupole-Orbitrap Mass Spectrometer. Briefly, the digested samples were cleaned on-line using the C18 trap column (Thermo Fisher Scientific, PN: 164564) followed by reversed-phase separation using the analytical CI 8 column (75 μιτι i.d. x 15 cm, nanoViper, 3μιη particle size, Thermo Fisher Scientific, PN: ES800) with a 2-30% gradient of Buffer B using Buffer A (0.1% formic acid) and Buffer B (0.1% formic acid/99.9 % acetonitrile) at 0.300 μΙ7ιηίη.
[00103] Figure 4 shows that the IP-nanoLC-MS/MS analysis was able to identify 14 proteins in the multiplex assay panel 1. MS analysis of multiplex assay identified interacting proteins (KRAS-2b, MAPK8, and SOS1) of RAS-RAF-MAPK Pathway Targets. Table 6 provides listings of the antibodies used in this multiplex IP.
[00104] Figure 5 shows that the IP-nanoLC-MS/MS analysis was able to identify 12 proteins in the multiplex assay panel 2. Table 6 provides listings of the antibodies used in this multiplex IP.
[00105] Figure 6 shows that the IP-nanoLC-MS/MS analysis was able to identify 15 proteins in the multiplex assay panel 3. MS analysis of multiplex assay identified interacting proteins (PIK3CA, PIK3CB, and PIK3R1) of RAS-RAF-MAPK Pathway Targets. Table 6 provides listings of the antibodies used in this multiplex IP.
[00106] A summary of RAS-RAF-MAPK pathway proteins that were identified and quantified using the IP-MS methods described herein is provided in Figure 7. Most of the RAS-RAF-MAPK pathway targets were not identified in discovery MS and quantitated by targeted MS (PRM or SRM) without enrichment by immunoprecipitation.
[00107] Immunoprecipitation using particular selected antibodies resulted in a higher yield of RAS-RAF-MAPK pathway target proteins and less non-specific binding proteins than MS alone. IP-MS assay was also more successful than other commercially available non-MS assays. Furthermore, IP to MS analysis of the RAS-RAF-MAPK pathway proteins enabled identification of multiple isoforms, relevant protein interactions and phosphorylation sites. Three panels of mlP-tMS assays allowed simultaneous quantitation of 14, 12 and 15 RAS- RAF-MAPK pathway proteins in the low to sub-fmol range from unstimulated and IGF stimulated HCT116 cell lysates. Major advantages of the MS-based assay are high confidence in target identity coupled with simultaneous quantitation of multiple targets, interacting proteins and their phosphophorylated forms.
Next Patent: CELLULOSE ACETATE FIBERS IN NONWOVEN FABRICS